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ABSTRACT 
For many decades, fluorophores have been used to investigate natural systems, but 
autofluorescence and photobleaching diminish the detection capacity. Recently, BODIPY 
based lanthanide complexes have been synthesized and their photophysical properties have 
been investigated. These complexes exhibit higher emission efficiencies at NIR region with 
longer NIR lifetimes upon exciting at longer wavelength. 
In this study, two BODIPY based lanthanide complexes were synthesized and their 
photophysical properties were evaluated. BODIPY based ligands were synthesized with 
phenanthroline as the ligand binding group. These ligands exhibit strong absorption at 527 
nm and 532 nm, fluorescence at 540 nm and 548 nm with 0.55 (±0.0 l)  and 0.78 (±0.06) 
quantum yields. Upon exciting at 525 nm and by titrating with [Yb(TPP)(OAc)(MeOH)2] , 
both ligands formed 1 :  1 ligand to metal complexes exhibiting strong NIR emissions at 977-
1006 nm with two characteristic peaks correspond to unique Yb(III) transition between 
2Fs12 ground state and 2F1112 excited state ofBODIPY based Yb(Ill) porphyrin complex. 
The para substituted aromatic ring containing BODIPY demonstrated 4.97 ns excited state 
lifetime and the ortho substituted aromatic ring containing BODIPY demonstrated 7 .56 ns 
in the visible region. In contrast, complex l and complex 2 possessed 12.24 µs and 8.86 µs 
respectively. Excitation scan of both complexes showed the evidence of higher excitations 
at 440 nm and 525 nm suggesting both porphyrin and BODIPY moieties contribute for the 
lanthanide sensitization process. Further studies are required to address the underline 
chemistry behind the energy transfer mechanism of both complexes and how the geometry 
of formed lanthanide complexes affect the sensitization process. 
vii 
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1 . 1 .  Overview 
CHAPTER 1 
INTRODUCTION 
Understanding living systems in nature has long been a practice for different purposes, yet 
tracing biological systems effectively, efficiently, and accurately is a challenge.1 For many 
decades, fluorophores have been used to investigate these natural systems, but 
autofluoroscence arising from such systems diminish the detection capabilities resulting in 
lower selectivity and sensitivity. Also, the utilization of higher excitation energy sources 
to excite prevailing fluorophores causes photobleaching of analyzed samples. To overcome 
these mentioned detection barriers, lanthanide metal complexes have been synthesized and 
tested on physiological environments for the past 20 years.2 
Lanthanide complexes show luminescence with unique emission properties in near infrared 
(NIR) region but the emissions are poor due to lack of absorption capabilities. Owing to 
this problem, excitation of lanthanides requires strong light source (laser), which can also 
lead to photoblcaching of the analyte. To address this issue, organic chromophores can be 
synthesized with ligand binding groups. These chromophores are used to synthesize 
lanthanide complexes enabling them to excite at lower wavelengths (visible region). This 
sensitization process is an indirect excitation method which can enhance lanthanide NIR 
emission through the antenna effect. 3 So far, porphyrin, DOT A, and phenanthroline based 
lanthanide complexes have been synthesized that demonstrate NIR emissions; however, 
they require 300-450 nm range energy sources to excite the complexes.4•5•6•7•8 
1 
Recently, BODIPY (dipyrromethene) based lanthanide complexes have been synthesized 
and their photophysical properties have been investigated. These complexes exhibit higher 
emission efficiencies at NIR region with longer NIR lifetimes upon exciting at longer 
wavelengths. 9•1 0  
This previous work suggests us to functionalizing BODIPY chromophores further to obtain 
well stabilized novel Yb(III) complexes with higher emissions and longer lifetimes at the 
NIR region. These complexes can be evaluated as promising optical probes for medical 
diagnosis and imaging. 
1.2. Luminescence 
Luminescence is a phenomenon of light emission that indicates an excess over the thermal 
radiation and persists for a time beyond the period of electromagnetic 
oscillation. Luminescence is observed at any temperature while visible light from thermal 
radiation begins emitting at minimum temperatures of a few hundred degrees K, so 
luminescence is sometimes named as cold light. As luminescence lasts for a time beyond 
the period of electromagnetic oscillation, it can be differentiated from stray and reflected 
light. The luminescence includes a wide range of light emitting processes; their names 
originate from the diverse sources of energy that power them. Photoluminescence is one of 
the main categories in luminescence which further divides into fluorescence and 
phosphorescence.1 •1 1  
Photoluminescence, a luminescence enthused by light absorption in UV-Vis-NIR spectral 
region, denotes any process in which a material absorbs electromagnetic energy at a 
definite wavelength and then emits part of it at a longer wavelength transforming a part of 
absorbed light into luminescence, while the remainder dissipates as heat or molecular 
2 
vibrations. Since there are many reliable and inexpensive excitation sources available and 
the effect can often be observed with the naked eye, photoluminescence is the most popular 
type of luminescence used for many applications. Usually the excitation source emits in 
the UV region and the photoluminescence occurs in Vis or NIR.1 • 12 
Due to the delay between the absorption of energy by the material and re-emission process, 
atoms or molecules can remain in an excited state for a short period, which is defined as 
the lifetime of excited state. Based on practical observations, this delay time can differ by 
many orders of magnitude for different materials and two main types of photoluminescence 
processes were identified. Fluorescence has a shorter excited state ranging from 1 0-12 to 
1 0-7 seconds ( s ), and phosphorescence has a much longer excited state up to a few hours 
and even days.1 • 13 
1.2.1. Fluorescence 
1.2.1.1. Light -Matter Interaction 
Fluorescence is a "fast" photoluminescence phenomenon. Some atoms and molecules 
absorb light at a particular wavelength and consequently emit a longer wavelength range 
after a short interlude. Every atom or molecule has a series of closely spaced energy levels. 
Atoms and molecules can go from low to high energy levels when they absorb light equal 
in energy to the difference between the ground and excited energy levels. Even though 
every atom and molecule possesses different energy levels, only few interact with light to 
undergo excitation and exhibit fluorescence.1 1 
For polyatomic molecules, the orbital angular momentum of a particular state related to the 
spin is given by M = 2.S. + I where M refers to multiplicity of the particular state. When 
3 
polyatomic molecules have paired electrons S = 0( + !. - !.), and the multiplicity becomes 2 2 
1 and is referred to as a singlet electronic state. When there are 2 unpaired electrons in a 
molecule, S = 1( + � + �) and multiplicity becomes 3 which is called a triplet state. When 
a discrete quantum of light is irradiating a molecule, it is absorbed within 10-15 s, and 
transitions to higher electronic states is observed. This absorption energy is unique to each 
molecule and it is used to characterize specific molecular structures by analyzing the 
ultraviolet and visible spectra due to the ground to singlet (SI, S2) electron transfer 
process.1 This absorption process typically starts from the lowest vibrational level of the 
ground state. Excited electrons stay in the excited state for a certain period of time. There 
are collisions between excited molecules resulting in energy loss leading those electrons to 
return to the excited singlet state; thereby, if further energy remains after collision, 
electrons return to the ground electronic state by releasing energy. This energy emission 
process is known as fluorescence (Figure l.2.). 14 
1.2.1.2. Emission Process 
Fluorescence emission can take place in different ways. So far, a few main pathways are 
known to be related to fluorescence emission. Stokes fluorescence, which is observed in 
solutions, is related to reemission of photons having lower energy compared to absorbed 
energy. Anti-Stokes fluorescence occurs when thermal energy is provided to a compound 
or if it has many vibrational energy levels with higher populations, emitting more energy 
than it absorbed. Resonance fluorescence cannot be observed in a solution phase, which 
refers to reemission of photons containing the same energy as absorbed; thus, emission 
wavelength is the same as excited wavelength. This phenomenon is called Rayleigh 
4 
scattering and occurs at all wavelengths. In terms of intensities related to emission and 
excitation they are varied, but are typically low intensity which cause problems when 
fluorescence is used for detection purposes. The Raman effect is another scattering form 
rdated to Rayleigh scattering, which occurs due to vibrational energy being added to, or 
deduced from, the excitation photons. Even though Raman scattering signals are weaker, 
they are significant if high energy excitation sources are used.1. 12-13 
1.2.1.3. Excitation Spectrum 
A fluorescent molecule often exhibits two characteristic spectra. The excitation spectrum 
shows the relative efficiency of exciting radiation to cause fluorescence at different 
wavelengths. This spectrum is usually similar to the absorption spectrum of the same 
molecule obtained from a spectrophotometer, but may deviate due to different instrumental 
parameters. The excitation spectrum is often acquired from a fluorometer. To match the 
absorption spectrum to the excited spectrum, some corrections must be done such as 
changes in photomultiplier response, changes in the band width of the monochromator or 
light source, and consistency in the slit of fluorometer. The peak position of excitation 
spectrum is chosen to excite the molecule to observe fluorescence emission. 
1.2.1.4. Emission Spectrum 
Emission spectrum is the second characteristic spectrum of a fluorescent molecule that is 
recorded due to the reemission of radiation absorbed by the molecule. The shape of this 
spectrum and the quantum efficiency is independent from the excitation wavelength used 
to obtain the emission spectrum. When using a different wavelength than the excitation 
maxima (ft.ex) to excite the molecule, emission intensities in the emission spectrum can be 
5 
lower as absorption is lower at other wavelengths than A..:x. Excitation and emission spectra 
display mirror images of each other, which is useful to understand the transitions among 
first excited state or higher electronic levels. 
The presence of other peaks is an indication of impurities or Rayleigh or Tyndall scattering. 
If the solution is very dilute, Raman scattering is also observed in the emission spectrum. 
If the molecular structure is very complex and less symmetric, wider fluorescence bands 
could be observed in the emission spectrum. If one compound has several excitation peaks 
and emission peaks or two compounds have the same excitation peaks but different 
emission peaks or vice versa, these properties can be used to distinguish one molecule from 
the other, which are very useful parameters to develop analytical tools to identify such 
molecules. This ability of fluorescence spectroscopy is a major advantage over absorption 
spectroscopy, which improves the selectivity of analytical methods developed related to 
fluorophores. The stoke shift is the physical constant that refers to the difference between 
the maximum wavelengths of excitation and emission spectra (Figure 1 .1 .). This constant 
represents the energy loss in between the excitation and emission processes before the 
molecule returns to ground state. 
Stoke Shift= 107 II A..:x- II Aem 
A..:x =Corrected maximum wavelength for excitation (nm) 
A.cm= Corrected maximum wavelength for emission (nm) 
6 
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Excitation spectrum Emission spectrum 
Figure 1.1. Excitation, emission spectra of a fluorophore with the stokes shift 
1.2.1.5. Fluorescence Quantum Efficiency 
The ratio of total energy emitted by any molecule per quantum of energy absorbed is 
referred to as quantum efficiency, which is a measure of the probability of the excited state 
being deactivated by fluorescence emission rather than the non-radiative mechanisms. 15 
Quantum yield in the visible region is measured using the following equation: 
0X = 0 T [ Gradx ] [�]2 S GradsT nsT 
0x =Fluorescence quantum yield of compound 
0sT = Standard fluorescence quantum yield (A.ex= 480 nm) 
Gradx = Gradient from the plot of the intergraded fluorescence intensity vs 
absorbance of l.igands and complexes with different concentrations 
GradsT =Gradient from the intcrgraded fluorescence intensity vs absorbance of 
standard 
nx =Refractive index of the solvent used to dissolve the compound 
nsT = Refractive index of the compound used to dissolve the standard 
ln practice, it is quite difficult to measure the quantum yield due to some important 
considerations. Concentration effects, solvent effects and validity of standard samples must 
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be considered when taking the measurements for a particular compound. Choosing a 
correct concentration range and obtaining data at different absorbance values can ensure 
the linearity, thereby, giving a reliable quantum yield value for a specific fluorophore.1 
I. 2. 1. 6. Lifetime of Excited State 
The mean lifetime that a fluorophore spends in the excited state before emitting photons 
and comes back to the ground state is known as lifetime of excited state. This is an intrinsic 
property of a fluorophore which does not depend on its concentration, sample thickness, 
method of measurement, absorption of the sample, fluorescence intensity, photo-bleaching, 
or the excitation intensity but can vary from picoseconds to nanosecond scales depending 
on the nature of the fluorophore. Lifetime can be measured either by frequency domain or 
by time domain methods. The fluorescence lifetime is measured from the slope of the decay 
curve. Many fluorescence detection methods are available related to time-correlated single 
photon counting (TCSPC). TCSPC enables simple data collection and improves the 
quantitative photon counting.1• 14• l6 
1.2. 1 .7. Factors affecting/or thefluorescence intensity 
There are three major factors that can affect the fluorescence intensity. The equation below 
reveals the concentration-fluorescence intensity relationship. 
F = Fluorescence intensity 
0 = Quantum efficiency 
lo= Incident radiation power 
€ = Molar absorptivity 
b = Path length of the cell 
c =Molar concentration 
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If the quantum yield is high, that indicates the sample has higher fluorescence intensity. 
According to the equation, more intense radiation power should give a higher fluorescence 
intensity, but practically it can cause photodecomposition of the sample. To emit 
fluorescence, molecules must first absorb radiation so if a compound has a higher molar 
absorptivity, fluorescence intensity will be higher. When the sample concentration of a 
particular fluorophore is higher, fluorescence intensity is decreased due to light scattering 
and inner cell effect. 1 • 15• 17 
1.2.J.6. Limitations of fluorescence 
There are some limitations associated with fluorescence detection and fluorophores. The 
major issue with fluorescence detection is that it is strongly dependent on environment 
factors such as pH, ionic strength, and temperature. Additional limitations arise when using 
ultraviolet light as the excitation source because it leads to photochemical decomposition 
of the fluorescent compound. Using longer wavelength radiation, measuring the 
fluorescence immediately after the excitation, and storing fluorescence active samples in 
amber color containers reduces the photochemical decomposition of these types of 
compounds. Next the viscosity of the medium can affect the fluorescence. If the viscosity 
is higher, higher fluorescence can be observed, so the fluorescence of most of the 
compounds can be increased by using viscous solvents such as glycerol or gelatin. This 
observation is due to fewer collisions in a viscous solvent and less energy reduction among 
the molecules in excited state. Fluorescence quenching due to temperature, oxygen, 
concentration, and impurities can also be observed as a result of the interaction of 
fluorophores with the surrounding.13• 18 
1.2.2 Phosphorescence 
Phosphorescence is a "slow" photoluminescence process. In contrast to fluorescence, it 
demonstrates itself as a glowing that lasts long after the excitation light is gone. 
Phosphorescent materials are usually called "glow-in-the-dark". Phosphorescence is most 
likely to occur in molecules with restricted vibrational freedom such as aromatic molecules 
and their derivatives. The light emission process has a delay due to an electron undergoing 
a spin-flip to relapse to ground state, which normally takes I 0-3 to 102 s. The light emission 
is delayed long enough so that materials glow in the dark after exposure to light. 
Phosphorescence usually begins from the lowest vibrational level of the lowest triplet state 
(To) and terminates in any of several ground state vibrational levels. Spectroscopic study 
of phosphorescence provides information related to the triplet state of every type of 
molecule. Collisional deactivation by solvent molecules, photochemical reactions, energy 
transfer processes, and quenching by paramagnetic species impede the detection of 
phosphorescence in fluid media (Figure 1.2.).18-19 
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Figure 1.2. Fluorescence and phosphorescence processes 
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1.2.3. Fluorophores for medical diagnosis 
Among fluorescence and phosphorescence, fluorescence is used for various medical 
purposes. Fluorophores are merged on aromatic molecules that show fluorescence upon 
excitation. Recently, applications of fluorophores for medical diagnostic purposes have 
become a common practice with advanced detection tools. In molecular biology, planar 
and heterocyclic molecules exemplified by fluorescein (aka FAM), couma1in, and Cy3 are 
very commonly employed for different imaging purposes. Indocyanine green (ICG) and 
fluorescein have been widely used fluorophores for over 30 years.20 The PET 
(photoinduced electron transfer) mechanism is applicable to a broad range of fluorophores 
such as BODIPYs, rhodamines, fluoresceins, cyanines, and so on (Figure 1.3.). Each of 
these molecules has a characteristic absorbance spectrum and a characteristic emission 
spectrum enabling them to act uniquely in the biological systems for sensing and imaging.21 
HO 
Figure 1.3. Small-molecule fluorophores with representative cores including 
fluorescein, rhodamine (rhodamine green), cyanine (Cy5.5) and BODIPY (BODIPY -
FL) cores21 
For example, indocyanine green (ICG) and fluorescein are used for the detection of bile 
leakages, fluorescence-navigated sentinel node biopsy, and NIR photodynamic therapy for 
human hepatocellular carcinoma cell line for tumors. 5-Aminolevulinic acid is used for 
photodynamic diagnosis of gastric cancers and for photodynamic detection of lymph node 
metastases in gastrointestinal cancers, while methylene blue and fluorescein are used to 
1 1  
ureter identification. The glutaryl phenylalanine hydroxymethyl rhodamine green (gPhe­
HMRG) probe is a fluorescent probe which can be activated by chymotropsin secreted in 
pancreatic juice and emit HMRG florescence (Figure 1.4). gPhe-HMRG has been excited 
at 490 run and emission was observed at 520 nm only when it is hydrolyzed by 
chymotrypsin which indicates the pancreatic leakages.22 
I 
H:l\ 
Figure 1 .4. Structures of glutaryl phenylalanine hydroxymethyl rhodamine green 
(gPhe-HMRG) probe is activated with chymotrypsin secreted in pancreatic juice and 
emits HMRG fluorescence22 
Most fluoropbores for medical applications are organic molecules and emit in the visible 
region. In order to afford new probes and reagents for applications in chemical biology, 
Stains et. al developed new near-infrared fluorophores that display remarkable 
photostability and brightness (Figure 1.5.). NIR fluorescence probes attribute deeper tissue 
penetration and mitigate issues related to autotluoroscence from native tluorophores in 
biological samples. The introduction of novel chemical functionality into these scaffolds 
al lows for the tuning of physical properties such as cell pem1eabil ity and generation of self­
reporting small molecule delivery reagents. These scaffolds can be used to develop 
bioimaging reagents for proteins, small molecules, and post-translational modifications. In 
addition, these fluorophores have been explored as promising targeted drug delivery 
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reagents. These Nebraska red dyes exhibit excitation and emission above 600 run and show 
improved detection sensitivities. 23 
Figure 1.5. Nebraska red dyes23 
Stains et. al. also developed fluorophore scaffolds as a strategy to develop ratiometric 
chemodosimctcrs by slightly modifying the Nebraska red dyes. Phosphorus atom in 
Nebraska red dyes were replaced with boron and silicon atoms where they could introduce 
novel NIR emitting fluoropbores that undergo oxidation in the presence of H202. (Figure 
1.6.). These fluorophores have been developed as endogenous H202 sensors by overcoming 
the spectral overlap of the reactants and products before and after the oxidation by H202. 
The fluorophores have also produced significant blue shifts (>66 nm) in excitation and 
emission maxima enabling them to detect endogenous H202 in HeLa cells providing 
evidence for the ability to rationally tune ratiomctric sensors using the chemoselective 
alteration of fluorophore scaffolds (CAFS) approach. From the SiOH2R scaffold, 
researchers have first demonstrated a method to detect Tamao oxidation of a biologically 
relevant signaling molecule.24 
13 
111nm shift 
SiOH2R 
Figure 1.6. Chemoselective alteration of fluorophore scaffolds24 
BODIPY (4,4-difluoro-4-bora-3a,4a-diaza-s-indaccnc) is another class of tluorophores 
frequently used as pl-I, peroxynitrite, and nitric oxide sensors. A library of pl-I-activatable 
probes based on the BODIPY fluorophore has been created (Figure 1 .7.), each activating 
at a specific pH; these were conjugated to a monoclonal antibody targeting a cancer-
specific cell surface receptor. These pH activatablc probe-antibody conjugates were almost 
non fluorescent under neutral pH conditions; however, afier selective uptake by tumor cells, 
the conjugate was transported to the lysosomc to undergo degradation at pH 4-5. Upon 
activation, the probe was highly fluorescent. The ex vivo imaging and in vivo imaging of 
human HER2-positive lung tumors in mice was performed with a humanized antibody 
against HER2 and trastuzumab, then conjugated with a BOOJPY-based pH-activatable 
small-molecule fluorophore. The probes had no fluorescence signal on the surface of 
HER2-positive cells but internalized and activated the signal only in the lysosome in vitro 
and showed highly specific detection of tumors with minimal background signal in vivo.20 
14 
OH 
Figure 1.7. pH activatable BODlPY-based fluorescent probes20 
1.3. Fundamentals of Lanthanides 
Due to the understanding of the biomedical applications, researchers have broadened their 
horizon of lanthanide chemistry to investigate the rare earth metals and their complexes 
addressing the spectral, magnetic and coordinative properties along with physical and 
chemical properties. 25 
In 1 937, J. H. van Vleck published a research paper titled as "The Puzzle of Rare-Earth 
Spectra in Solids" which attracted the scientific community to the unique lanthanide optical 
properties. This research work summarized the discovery of all the natural lanthanide 
elements between 1803 and 1907. The discovery of highly emissive Y203:Eu(III) material 
was one big step in understanding lanthanide luminescence. The other important findings 
were the discovery of purely inorganic neodymium Y AG (Yttrium Aluminium Gamet) 
lasers in 1964 and Er-doped optical fibers for telecommunications in 1987. 26 
The science community looked forward to a bright future of luminescent coordination 
compounds starting from the mid-seventies after the introduction of bioprobes by Finnish 
researchers. They synthesized Eu(Ill) and Tb(Ill) (later also Sm(III) and Dy(III)) 
polyaminocarboxylates and �-<liketonates as bioprobes in time-resolved luminescent 
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(TRL) immunoassays. Since then, lanthanide luminescence conquered many other 
techniques used for medical diagnosis. Nowadays, optimization ofbioconjugation methods 
for lanthanide luminescent chelates, homogeneous TRL assays, and time-resolved 
luminescence microscopy (TRLM) are some of the major applications of lanthanide 
luminescent bioprobes (LLBs) in many fields of biology and medicine.26 
The finalized f-block contains 1 5  lanthanide metals starting from Lanthanum (La, 57), 
followed by Cerium (Ce, 58), Praseodymium (Pr, 59), Neodymium (Nd, 60), Promethium 
(Pm, 6 1 ), Samarium (Sm, 62), Europium (Eu, 63), Gadolinium (Gd, 64), Terbium (Tb, 65), 
Dysprosium (Dy, 66), Holmium (Ho, 67), Erbium (Er, 68), Thulium (Tm, 69), Ytterbium 
(Yb, 70), and Lutetium (Lu, 7 1 ).27 
1.3.1. Physical properties 
Most of the lanthanide elements are silvery-white metals, which tarnish when they are 
exposed to air, forming oxides. These metals are relatively soft and their hardness barely 
increases barely with higher atomic numbers. Considering from left to right across the 
period, the radius of each 3+ ion steadily decreases, which is called "lanthanide 
contraction." Most of these rare earth metals are strongly paramagnetic and attributed with 
higher melting and boiling points. Under UV light, many rare earth compounds exhibit 
strong fluoresce. Lanthanide ions tend to be pale colors, due to weak, narrow, or forbidden 
f-f optical transitions. 21-28 
1.3.2. Chemical properties 
The lanthanide metals are highly electropositive and reactive. Except for Yb, lanthanide 
reactivity depends on their size. Lanthanide metals easily react with water and liberate 
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hydrogen slowly in cold water and quickly in hot water yielding hydrous oxides. 
Lanthanides commonly bind to water molecules. They react with diluted acidic media 
releasing hydrogen rapidly at ambient temperatures to give an aqueous solutions of Ln(Ill) 
salts. Many of them ignite and bum vigorously at elevated temperatures. They are strong 
reducing agents and many of their compounds are ionic. Lanthanides show higher 
coordination numbers, generally greater than 6. Usually observed coordination numbers 
are 8 and 9 but can be as high as 12. The most common oxidation state of these rare earth 
metals is + 3, and due to the large sizes of the Ln(III) ions, the bonding is predominantly 
ionic and the cations are the typical class-a acids, but +2 and +4 oxidation states can also 
be observed in some metal complexes. Although the + 3-oxidation state governs lanthanide 
chemistry, Ln(II) are easily made reacting Ln(III) with an electron delocalizing ligand, 
generating oxidation states of +2 and +4. For instance, Ce(IV) and Eu(ll) ions are found to 
be very stable in water and are strongly oxidizing and strongly reducing respectively. Due 
to the stability of the 4f7 configuration, Tb(IV) ion also shows stability.25 
Many trends linked with the ionic radii are observed across the lanthanide series. When 
Ln(III) radius decreases, the salts become slightly less ionic, and reduced ionic character 
in the hydroxide indicates a reduction in alkaline properties. Though Yb(OH)3 and 
Lu(OH)3 are alkaline, they can be barely solvated in hot concentrated NaOH. According to 
this change, the [Ln(H20)x]3+ ions have a potential to hydrolyze, and hydrolysis can only 
be avoided by using higher acidic media. However, solubility cannot be simply related to 
the cation radius. No consistent trends are apparent in aqueous or nonaqueous solutions, 
but a realistic dissimilarity can be seen between the lighter "cerium" lanthanide complexes 
and the heavier "yttrium" lanthanides. The occurrence of divalent state in Eu(II) and Yb(II) 
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can be explained by the stabilizing effect of half (4f7) and completely-filled (4f4) shells of 
those ions.27• 29 
1.3.3. Formation of complexes 
Over the past years, several approaches have been developed to design mono- and 
polymetallic lanthanide-containing molecular and polymeric assemblies. Except for the 
utilization of polydentate chelating agents (e.g., P-diketonates, polyaminocarboxylates), 
strategies related to the making macrocyclic receptors, either (a) preorganized, (e.g., 
cryptands or crown ethers), or (b) predisposed, (e.g., large macrocycles or cyclen 
derivatives and calixarenes functionalized with pendant arms), (c) podands, or (d) self­
assembly processes have been tested to form lanthanide complexes (Figure 1 .8.). 
(a) Pre-organized macrocycles 
Preorganization occurs according to the lock and key principle. Metal ions are encapsulated 
into preorganized receptors such as coronands or cryptands depending on the size match 
between the cavity and the metal ion (Figure 1 .8.a.). The ionic radius of Ln(III) ions varies 
little along the series [� ionic radius (La-Lu) � 0. 1 8  A for coordination number 9; the range 
of ionic radius between consecutive Ln(Ill) ion is 0.01 -0.02 A] while the receptors do not 
undergo any conformation changes during the complex formation step. This preserved 
conformation of free and bound receptors reduces the reorganization work on 
complexation. However, due to the practical difficulties of size matching between the 
receptor cavity and lanthanide ions, scientists introduced the strategy to use disposed 
macrocycles to synthesize lanthanide complexes. 
18 
(b ). Pre-disposed macrocycles 
Owing to the conformation changes upon complexation, pre-disposed macrocycles form 
stable complexes with lanthanide ions by the enthalpy gained host-guest interaction. In 
this strategy, 1 ,4,7,1 0-tetraazacyclododecane-N,N',N",N"'-tetraaceticacid (DOTA) forms 
the most stable Ln(lll) complexes (pLn :::::: 2 1 -22) (Figure 1 .8.b ). These receptors form an 
induced cavity (known as Induced Fit Principle) with pendant arms that can wrap the metal 
center (e.g., cyclen or calixarene derivatives). Difficulties in synthesizing bidentate or 
tridentate arms Jed scientists to synthesize small anchors with aromatic rings. 
(c). Podands 
Podands allow the change number of donor atoms easily and they are less pre-disposed 
than the pendant arm-fitted macrocycles yet require some conformational changes to form 
the metal complexes. This challenge was overcome by introducing weak noncovalent 
interactions, such as hydrogen bonding. This allows to organize the arms of the donor in a 
favorable conformation as depicted in Figure 1 .8.c. A rare trifurcated hydrogen bonding 
of the receptor, forms the three coordinating units with a favorable conformation 
maximizing Ln(lll) ions interaction. 
( d). Self-assembly processes 
Self-assembly process is governed by the strong ion-dipole interactions and the formation 
of host cavity due to noncovalent interactions between ligand stands. For instance, three 
benzimidazole moieties are arranged according to interstrand n:-n: interactions among 
aromatic rings and ion-dipole interactions (nine Ln-N ion-dipole bonds) as illustrated in 
Figure 1.8.d. Also number of other research work shows that, self-assembly processes 
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yield more favorable complex formation over the other mentioned strategies, enabling the 
synthesis of stable multimetallic edifices and devices in the future.25 
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d. Self-assembly processes 
Figure 1.8 Synthetic strategies used to insert lanthanide ions into molecular 
edifices25 
1 .4. NJR Emitting Lanthanide Complexes 
1.4.1. NIR emission 
1.4. 1 . 1. Lanthanide NIR emiss io n  
Considering the spectral properties of lanthanide complexes, due to their (Xe] 4r15s25p6 
electronic configuration, luminescence can be observed from f-f transitions in the 4r1 shell 
(Figure 1.9.). This excitation can be hindered due to the shielding of 5s and 5p orbitals. 
This shielding can cause low absorptivity and thereby yield lower emissions and sharp 
narrow bands with low molar absorption coefficients. Not only that but also f-f transitions 
are both Laporte and spin forbidden.30 This fact explains the long-excited state lifetimes 
from milliseconds to the microseconds, enabling time-gated or time-resolved live cell or in 
vivo imaging applications.28 
NIR luminescent lanthanide complexes show higher selectivity and sensitivity. The sharp 
emissions around NIR region avoid the misleading background fluorescence generated 
from biological systems, yielding sharp emission bands. The long luminescent lifetimes of 
these complexes enhance the assay sensitivity through time-resolved measurements and 
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reduce the overlapping autofluorescence. Most of tbe lanthanide complexes diminish 
photobleaching. The multiphoton excitation technique allows these complexes to excite in 
NIR region. Poor efficiencies and the requirement of higher exciting light sources have 
led scientists to develop NIR emining lanrhanide complexes with organic chromophores.31 
In 1940, Weissman et al. revealed the utilization of lanthanide luminescence complexes of 
terbium and samarium metals for biomedical applications by introducing the antenna effect 
to sensitize lanthanide metal complexes.32 
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Figure 1.9 Characteristic lanthanide emission peaks of Tb(lll), Sm(III), Dy(III), 
Eu(Ill), Nd(lll), Er(lll), Ho(III), Tm( f l l) and Yb(IIJ)32 
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1.4. 1.2. Energy transfer mechanism in lanthanide organic complex 
Indirect excitation or the antenna effect is the most accepted mechanism used to describe the 
energy transfer process of organic lanthanide complexes. The energy transfer process starts by 
exciting the singlet ground state (So) of lanthanide complex to its excited state (Si) due to the 
absorption of energy. Then, energy is transferred from Si to the triplet excited state (Ti) of the 
ligand through intersystem crossing followed by an intramolccular energy transfer process from 
Ti of the ligand to one of the excited 4fstates of the Ln (Ill) ion (Figure 1.10.). As lanthanide 
luminescence occurs due to intra-4f transitions within the ion, Dexter stated that for an efficient 
energy transfer, energy difference (till) between the triplet state of the organic ligand and 
resonance level of the LnfII ion plays a critical role in this proccss.32 When the energy gap is 
considerably larger, the energy transfer rate constant decreases due to the reduction of overlap 
between the donor and the acceptor energy levels in the organic lanthanide complex. There is 
also a possibility to observe energy back-transfer when the reverse condition happens in a 
complex, and to prevent such back-transfer processes, the energy gap must be at least 
I 0 ksT (2000 cm- i ). In order to understand the underline chemistry behind the energy transfer 
process of organic lanthanide compounds, knowledge related to the donor triplet excited state 
of organic ligand and the accepting energy levels of the Ln(ITI) must be taken into account.33 
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Figure 1 . 10  Energy transfer mechanism in lanthanide organic complexcs33 
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1.4.2. Lanthanide complexes 
1.4.2.1. DOTA Complexes 
Magnetic resonance imaging (MRI) has been used for many years, therefore the demand 
of MRI contrasting agents increases day by day. Among the prevailing contrasting agents, 
gadolinium(III) chelates are clinically the most commonly used tissue specific marker. 
Due to the toxicity of free gadolinium(Ill) (LOSO = 0.2 mmol · kg-1 in mice), relatively 
high concentration of contrast agents is required for MRI scan (up to 0.3 mmol per kg body 
weight). To maintain a low free lanthanide ion concentration, and to ensure kinetic and 
thermostatic stability of the gadolinium(III)complexes, strong chelating agents are used.4 
Currently, acyclic diethylenetriaminepentaacetic acid (Gd(Ill)-DTPA, Magnevist®, Bayer 
Healthcare, Berlin, Germany) and the cyclic 1 ,4, 7, 1O-tetraazacyclododecane- 1 ,4,7, l 0-
tetraacetic acid (Gd(III)-DOT A,Dotarem®, Guerbet, Hongkong, China) are the most 
commonly used contrasting agents for imaging techniques. Most of these complexes are 
eight coordinated and allow binding of one water molecule directly to the metal center 
yielding higher stability (logK =25.3 and 20.1 for DOTA and DOTA-propylamide 
respectively). 34 
MRI is a technique with higher special resolution and depth penetration, yet it lacks higher 
sensitivity. Scientists have done some research work to combine other imaging techniques 
such as PET (photoinduced electron transfer) probes to enhance the sensitivity of MRI 
technique. This idea will open the understanding of morphology (MRI) and information 
about biochemical processes (PET) related to the human body. Optical imaging is another 
method which lacks spatial resolution and depth penetration but has a good sensitivity. 
Combining optical probes with DTP A, DOT A such as luminescent metal complexes, 
24 
luminescent polymers in lipophilic aggregates, dendrimers, and organic dyes (quinolone, 
tluoresceine, rhodamine, naphalimide) have also improved the sensitivity.34 BODIPY (4,4-
difluoro-4-bora-3a,4a-diaza-s-indacene) is another organic dye that can be tuned to excite 
in the visible region. BODIPY dyes have comparatively higher absorption coefficients and 
fluorescence intensities that save them using as biological labeling. These dyes are stable 
in biological systems and possess higher quantum yields. 
In 20 15 ,  Tatjana et al. functionalized BODIPY (4,4-difluoro-4-bora-3a,4a-diaza-s­
indacene) dyes by converting primary amines into azides via a copper flow reactor using 
an in-situ catalyst generated from the metallic copper to synthesize a Gd-DOTA-BODIPY 
derivative as a bimodal contrast agent for MRI and optical imaging (Figure 1 . 1 1 .). The 
absorption spectrum of this adduct shows A.abs(max) at 503 nm in aqueous medium assigned 
to the So-+S1 transition. There was another considerably weak peak around 360 nm, which 
was due to So-+S2 transition. This Ln-DOTA-BODIPY adduct was water soluble and 
emitted bright green fluorescence upon excitation at 366 nm. This complex shows 
excitation maxima at 503 nm and emission maxima at 523 nm. 
Since the optical properties of the BODIPY dyes can be altered by introducing conjugation 
via different substituents on BODIPY core, there is a potential to red shift main emission 
band, which is an advantage for biomedical applications. Tuning this complexes to optical 
imaging window from 665 to 900 nm can prevent hemoglobin, deoxyhemoglobin, and 
water absorptions thereby improving the sensitivity. However, care must be taken to 
mindfully alter the BODIPY core as introducing more conjugated substituents can increase 
the hydrophobicity and reduce the solubility of Ln-DOT A-BODIPY complex in aqueous 
media.35 
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Figure 1 . 1 1 .  Gadolinium(III) DOTA complex functionalized with a BODIPY 
derivative35 
In 2008, by introducing an azathioxanthone sensitizer and a pH dependent alkylsuJfonamide 
moiety to DOTA, two pH-responsive ratiometric Eu(III) complexes were synthesized (Figure 
1.12.). Using 680/589 nm intensity ratio vs pH plot, scientists could determine the local pH 
within the cells. This emission intensity ratio vs pH plot gives accurate pH measurements within 
the range of pH 6-8 and allow to record intracellular pH by microscopy. The coordination 
environment around the Eu(TII) ion has a great impact on the spectral properties, circular 
polarization of emission and lifetime of these complexes. The pH-dependent ligation of a 
sulfonamide group associated with large changes in the t:J = 2 (around 620 nm) and !l.f = 
4 transitions (680-700 nm). 
Figure 1 . 12 .  pH Dependence of the europium emission spectrum showing the two 
Eu(TTI) species (lcxc = 380 nm, 298 K, 0. 1  M NaCl) 
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In 20 1 1  Simon et al. synthesized bimodal, di metallic lanthanide complexes that bind to 
DNA (Figure 1.13). Fol.lowing a straightforward method of three consecutive steps two 
different DOTA-AQ ligands were synthesized. First diamino AQs (aromatic quinones) 
were converted to bis- chloroacetamides and attached to pre-formed cyclen units. Resulting 
hexa esters were hydrolyzed by TF A to obtain the free ligands. Di metallic complexes were 
obtained by the reaction with two equivalents of Ln(OTf)3. Irradiating visible light to the 
chromophores (ex = 440 nm for Ln2-L l ;  A.ex = 400 nm for Ln2-L2), resulted in 
characteristic lanthanide emissions in the near-IR region.36 
Ln2-Ll 
Ln2-L2 
1050 lZSO t 4SO 
wavelength / nm 
1650 
Figure 1.13. Ln2-L l  and Ln2-L2 Complexes and emission spectra for Ln2-L2 (red-
Yb, blue-Nd, green-Er) measured in D20 using .?..ex= 400 nm.36 
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1.4.2.2 Porphyrin Complexes 
As porphyrins form stable lanthanide complexes that show intense emissions in NIR 
region, they play an important role when using them in medical and photochemical 
applications. By introducing different substituents in the meso- and/or �-positions of the 
porphyrin ring change physical and chemical properties of lanthanide porphyrin 
complexes, which is an advantage for using them in different fields in medicine. 
Since porphyrins accumulate in various types of tumor micro vessels and cancer cells, 
many different types of porphyrins have been synthesized. The first Yb-TPP 
(tetraphenylporphyrin) complex was synthesized in 1974. Then the Yb mesoporphyrine IX 
complex was synthesized and inserted to apomioglobin. Due to solubility issues with 
inorganic salts, under quite hard conditions, in the inert atmosphere and high-boiling 
solvents reactions were carried out with porphyrin macrocycle and ytterbium 
acetylacetonate for several hours to obtain soluble complexes. Asymmetric 
tetraarylporphyrin complexes containing ytterbium with three 4- methoxycarbonylphenyl 
groups, 4-hydroxyophenyl and 4-hydroxy-3-methoxyphenyl radicals or isomeric 3- and 4-
pyridyl fragments as the fourth substitute (Figure 1.14.), and by alkyl hydrolysis, 
corresponding triacids were synthesized. 
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COOCHj HOOC COOH 
COOCH;! COOH 
1 .  a. R = 4- OH-Ph 2. a. R = 4- OH-Ph 
b. R = 4-Py b. R = 4-Py 
c. R = 3-Py c. R = 3-Py 
d. R = 4-COOCH3-Ph d. R = 4-COOH-Ph 
Figure 1.14. Ytterbium tetraarylporphyrin complexes with asymmetrical substitutes 
A significant difference was observed in the excited state lifetimes of these ytterbium 
complexes of porphyrin ethers and acids as shown in Table 1 .1 .  According to the 
results, ytterbium complexes with hydrophobic tri- and tetra-methyl ethers showed 
higher excited states lifetimes ( 1 3-20 µs) than hydrophilic complexes. It is thought that 
hydrogen bonds formed by hydrophilic ytterbium complexes with water can quench the 
luminescence of these hydrophilic complexes. Incorporation of a pyridyl fragment led 
to a decrease the molecular symmetry, thereby lowering the lifetime compared to 
corresponding l d  complex (20 µs).37 
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Table 1.1.  Spectral luminescent characteristics of Yb(Iffi porphyrin complexes 
Compound Luminescence Lifetime (µs) 
Spectrum Amax nm 
(DMSO) 
l a  Yb( acac )-5-( 4-0 H- 982 16.3 
Ph) 10, 1 5,20-( 4-COOCH3-Ph)3 
l b  Yb(acac)-5-(4-0H- 983 1 3.4 
Ph) l 0, 1 5,20-( 4-COOCH3-Ph)3 
l e  Yb(acac)-5-(3-Py)- 10, 1 5,20- 983 14.8 
( 4-COOCH3-Ph)3 
2a Yb(Im)2-5-( 4-0H-Ph)- 982 3 
l 0, 1 5,20( 4-COOH-Ph)3 
2b Yb(Im)2-5-( 4-Py)- 10, 1 5,20-( 4- 976 6-7 
COOH-Ph)3 
2c Yb(Im)2-5-(3-Py)-l 0, 1 5,20-( 4- 983 5 
COOH-Ph)3 
Id  Yb(acac)-5, 1 0, 1 5,20- (4- 974 20 
COOCH3-Ph)4 
2d Yb(Jm)2-5 , 10, 1 5,20- (4- 980 8 
COOH-Ph)4 
In 2000, Williams et al, synthesized a palladium porphyrin complex which was covalently 
linked to a chiral lanthanide complex and successfully sensitized NIR emission from 
Yb(III) and Nd(III) at 529 nm (Figure 1.15.). Enhanced sensitization was observed in the 
absence of oxygen and in the presence of a nucleic acid. The highest emission was observed 
in deuterated solvents (a factor of 2.5 for Nd(lll) and a factor of 4 for Yb(III)), revealing 
OH oscillation alters the sensitivity of the excited ion. Degassed samples of Yb(Ill) and 
Nd(Ill) emitted at 980 nm and l 064 or 870 nm respectively. The energy transfer efficiency 
observed for Nd(llI) is higher than for Yb(III), due to better spectral overlap.30 
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Figure 1.15. Emission spectra for (RRR-R)-YbLI (295 K, 20% D20-CD30D, 5 
mM) in degassed solution (top), in aerated solution (bottom) and in the presence of 
0 . 1  mM [(CG)6]2,Aex= 529 nm30 
1.4.2.3. Phenanthroline Complexes 
3 
Figure 1.16. Lanthanide complexes of 2-thenoyltrifluoroacetonate complex38 
Lanthanide complexes of 2-thenoyltrifluoroacetonate complexes (Pr( III), Nd(III), Sm(lll), 
Eu(III), Dy(III), Ho(III), Er(III), Tm(III), Yb(III)) in an organic-inorganic hybrid material 
were synthesized by embedding the complexes in a solid matrix via 2-substituted 
imidazo[4,5-f]-l  , l  0-phenanthroline moieties (Figure 1.16.). High resolution luminescence 
spectra (Figure 1 . 17., 1 . 18.) and luminescence decay times were recorded for each 
complex.38 
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Wavenumber (cm"1) Wavenumber (cm·1) 
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a � b -::> < -� LJI ·;;; c:: u -.5 
600 800 1000 1200 1400 800 1000 1200 1<400 
Figure 1 . 1 7. Emission spectra for the covalently linked [Ln(tta)3(phen)] complexes 
in the TMOS-DEDMS sol-gel bulk sample, A.ex 370 nm. 
(a) Ln) Sm(III). The transitions start from the 4Gs12 state and end at the 6HJ levels ((J) 
5/2-1 5/2 for this spectrum) and the different 6FJ levels ((J) 5/2-9/2). 
(b) Ln) Nd(llI). All transitions start from the 4f 312 state and end at the 41J levels ((J) 
9/2-1 3/2)38 
Wavelength (nm) 
1 1500 11000 10500 10000 9500 9000 
d 
850 900 950 1000 1050 1100 1150 
Wavelength (nm) 
Figure 1.18. Emission spectra for the covalently linked [Ln(tta)3(phen)] complexes 
in the TMOS-DEDMS sol-gel bulk sample, Aex = 370 nm 
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(c) Ln) Er. The transition starts from the 411312 level to the 411s12 level. (d) Ln) Yb. The 
transition starts from the 2Fs12 level to the 2F112 level38 
[Ln(Por)(BDL)(OAc)] 
Figure 1 . 19. Ytterbium(Ill) monoporphyrinate complexes [Ln(Por)(BDL)(OAc)] 
complexes40 
In 2009, He et al performed a study on [Yb(TPP)(OOCCH3)(CH30H)2] and neutral 
bidentate NN ligands and were able to observe the formation of monoporphyrinate 
ytterbium(III) complexes (Figure 1 .19.).39 In 2010, same research group synthesized eight 
coordinated erbium(III) and ytterbium(III) monoporphyrinate 
complexcs([Ln(Por)(BDL)(OAc)]) and hybridized into silica xerogel framework via the 
coordination of 5-(N,N-bis(3-propyl)ureyl-1 , 1 0- phenanthroline.40 All the complexes show 
NIR emission upon exciting with visible light. lo their first work, eight-coordinate 
ytterbium complexes exhibited longer lifetimes and stronger NIR emission than the seven-
coordinate complexes (Table 1 .2.). But there was a decrease in the lifetimes after these 
complexes were combined into organic polymer PMMA. In their second study, lanthanide 
hybridized films resulted in characteristic NIR emissions at 1 538 nm with a l ifetime of 0.6 
µs and at 980 nm with a lifetime of 6.6 µs, for erbium and ytterbium respectively. There 
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was a 50 to 70% reduction in lifetime compared to corresponding parent complexes in 
toluene.40-4t 
Table 1.2. Photophysical data of synthesized complexes in toluene. The excitation 
wavelength was 532 run. The number in parenthesis is the lifetime 
Compound Near-infrared (�m, nm) (µs) Reference 
[Yb(TPP)(OAc)(Phen)] 980 ( 1 7  .29), 1 006 40 
[Yb(TPP)( 0 Ac)( 4-MePhen)] 949, 978 ( 1 7.29), I 005 40 
[Yb(TPP)( 0 Ac)( 4 7-MePhen)] 948, 978 ( 1 7  .82), I 005 40 
[Yb(TPP)(OAc )(EPO-Phen)] 948,978 ( 1 4. 1 2), 1 006 40 
[Yb(TClPP)(OAc)(5-NH2-Phen)] 980 ( l  l .6),1 002 4 1  
[Yb(TCIPP)(0Ac)(5-Me-Phen)] 948, 978 ( 1 9.37),1 006 4 1  
[Er(TClPP)(OAc)(5-NH2-Phen)] 1538 4 1  
[Er(TCIPP)(0Ac)(5-Me-Phen)] 1 539 4 1  
[Yb(TPP)(OAc)(DPA)] 950, 975 ( 1 1 .60), 1006,1 023 40 
1.4.2.4. BODIPY Based Lanthanide Complexes 
Though indirect lanthanide sensitization has been done with different ligand binding 
chromophores, applications of those lanthanide complexes are lacking due to their demand 
of high excitation wavelengths and emission efficiencies. BODIPY ( 4,4-difluoro-4-bora-
3a,4a-diaza-s-indacene) dyes along with ligand binding groups show remarkable spectral 
properties with high extinction coefficients ( 1 1 0,000 M"1cm-1) and high fluorescence 
quantum yields (60-90%). To harvest thest! beneficial properties, scientists have 
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functionalized the BODIPY core with different ligand binding groups and studied 
lanthanide NIR emission capabilities of these BODIPY based lanthanide complexes 
(Figure 1 .20.). 10 
a b 
Ln(Ll)(NOJ)J 
c 
Ln 
3 
Ln(L3)3 
eO 
MeO 
Ln(L21 or L22)3(tpy) R==H (L21) R=Br(L22) 
d 
I 
Ln(L4)3 
Yb 
3 
Figure 1 .20. BODIPY based lanthanide complexes10.44 
Considering the photophysical properties of prevailing BODIPY based lanthanide 
complexes, all complexes were excited using visible light, but some complexes showed 
low emission efficiencies in NIR region {Table 1 .3.). The Yb(Ll )(N03)3 complex 
synthesized by Btinzli et al. in 2006 showed lifetime of 9.7 µs with higher NIR emissions 
than corresponding Nd(III) and Er(ITI) complexes (Figure 1 .20.a), suggesting the higher 
potential of Yb(III) using as the most suitable lanthanide ions to observe indirect excitation 
with the LI ligand.42 
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T bl 1 3 Ph a e . .  h . l otop tys1ca properties o f BODIPY b d l h "d ase ant am e comp exes 
Lanthanide Complex Aex Aem (NIR Lifetime Reference 
(Excitation) Emission) /µs 
/nm /nm 
Er(L l )(N03)3 528 1 527 - 43 
Nd(L l )(N03)3 528 865 0.2 43 
Yb(L 1)(N03 )3 528 978 9.7 43 
Er(L21 )3(tpy) 583 1 530 - 9 
Yb(L21)3(tpy) 583 978 - 9 
Er(L22)3(tov) 583 1 530 - 9 
Yb(L22)3(tpy) 583 978 - 9 
Er(L3)3 522 1 382 - 1 0  
Nd(L3)3 522 1060 - 1 0  
Yb(L3)3 522 976,1003 19.78 1 0  
Yb(L4)3 543 975, 1 000 95.0 44 
In 201 1 two different ligands (Ln(L21)3(tpy), R=H and Ln(L22)3(tpy), R=Br) (Figure 1.20., 
b) were synthesized that altered the 2,6 positions and contained two methoxyphenyl 
substituents in the 1 ,7 position in the BODIPY core. Regardless of the incorporation of 
bromine into the BODIPY core, lanthanide complexes formed by both ligands showed very 
similar photophysical properties. Further investigations showed no triplet state emissions 
from Ga(III) for both ligands due to the lack of efficient intersystem crossing because of 
unfavorable molecular conformations. But, longer wavelengths in the visible range can be 
used to excite these types of complexes, which is favorable for biological applications.9 
The research work done by He and coworkers in 20 1 1  on BODIPY modified 8-
hydroxylquinoline ligand (8-HOQ-BODIPY(L3)) (Figure 1 .20., c) and the following 
related work on 8- HOQ-BODIPY-31 (L4) (Figure 1.20., d) showed strong NIR emissions 
for ytterbium complexes. 10· 43 The first work with 8-HOQ-BODIPY ligand yielded stable 
Yb(III), Nd(III) and Er(III) complexes, however in contrast to ytterbium complex, weak 
emissions were observed for neodymium and erbium complexes upon excitation at 522 
nm10. In their second study, under UV and visible excitation [Yb(8- HOQ-BODIPY-31)3] 
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gave a sharp peak at 975 run and a broader peak centering 1 000 nm due to typical 2Fs 2 -
2F112 transition for Yb(III) ion.43 The major difference between the iodized and non-iodized 
ligand containing ytterbium complexes is the NIR lifetimes. The non-exponential fitting of 
its emission decay curve at 975 nm of iodized complex was 95.0 µs which is much longer 
than non-iodized complex and clearly shows the heavy atom effect associated with iodine 
in the L4 ligand that facilitated to yield higher population in ligand triplet state. This longer 
lifetime of [Yb(8- HOQ-BODIPY-31)3) is favorable for probing and imaging applications 
in biological systems. 
LS L6 
Figure 1.21. BODlPY based chromophores used to synthesize lanthanide complexes44•45 
[n 20 13 ,  research work was done to understand the recognition ability of different trivalent 
lanthanide (La( J r r) , Gd(III), Tb(III), Dy( lII), Er(Ill) and Yb(Hl)) ions by calixa[ 4]crown 
ether appended BODIPY fluorescent probes (L5) (Figure 1 .21.). Ertul et al synthesized 
this L5 ligand which contained a calix[4]azacrown derivative capped with a two amide 
bridges with cone conformation bearing two BODIPY groups. The fluorescence intensity 
change was monitored upon complexation to understand the sensitivity of different 
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lanthanide ions.44 Results revealed that the metal ion binding caused to increase in the 
florescence intensity of L5 which is due to an intramolecular energy transfer process. In 
addition, selectivity experiments showed the ability of Yb(III) to recognize L5 was 
independent and not affected by other lanthanide ions. Therefore, these types of ligands are 
effectively used as chemical sensors, phase transfer catalysts or ion-binding processes. 
In 20 1 4  lanthanide metal complexes with L6 (BODIPY with Bispidines) were synthesized 
for dual imaging purposes (Figure 1 .2 1 .).45 Lanthanide ions (Tb(llI), Eu(III), Nd(III)) and 
BODIPY exhibited emissions enabling dual emission detection in both NIR and visible 
region respectively. NIR emission for these lanthanide complexes were observed when 
they were excited at 260 nm suggesting there is no contribution from the BODIPY core for 
lanthanide indirect sensitization. The bispidine subunit along sensitizes the lanthanide ions 
according to Dexter mechanism as T 1 is higher than lanthanide excited state. 
1 .4.3. Applications of NIR emitting Lanthanides 
Lanthanides and their complexes are a demanding field of study for the development of 
different biomedical tools.46 Among them are the development of lanthanide analytical 
probes as tools for biological labeling, imaging (MRI, optical) and therapy (PDT for 
cancer). The utilization of lanthanide ions as luminescent probes could show higher 
potential of successful applications.47 
In 20 1 1 , Wong et al synthesized a mitochondria specific water-soluble porphyrinato 
ytterbium complex linked to rhodamine B. This lanthanide complex exhibits strong two­
photoninduced NIR emissions (A.em = 650 nm, porphyrinate ligand n - n* transition; A.em 
= 1060 nm, Yb(Ill) 5Fs12 - 5f712 transitions; in DMSO) in aqueous solution with enhanced 
38 
Yb(III) NIR quantum yield ( 1  % at A.ex= 340 nm; 2.5% at A.ex= 430 nm). Due to the minimal 
cytotoxicity (ICso = 1 .2 mM) and the enhanced NIR emission properties of this ytterbium 
complex, it is used as a new time-resolved imaging probe enabling excitation and imaging 
in the NIR region.48 
In 20 1 1 ,  Cyclin A specific europium complexes with modified synthetic peptides and 
chromophores were synthesized by the same research group that demonstrated enhanced 
europium emission around 560-700 nm upon exciting in the biological window (700 nm-
1 000 nm). These lanthanide complexes are being tested as a new generation of bio-tracer 
for Cyclin A and applicable as potential candidates for both Cyclin A detection and 
inhibition of the cell division.49 
In 201 4  Wong et al also did some research work related to a photo selective, functional 
and Golgi apparatus specific, amphiphilic water-soluble ytterbium complex as a responsive 
dual probe capable of sensitizing emission within the biological window (660 and 750 nm), 
producing the singlet oxygen (UD = 0.45) and triggering local cell damage only upon 
exposure to visible and near-infrared laser excitation. The Yb(III) complex had a low 
cytotoxicity and highly emissive two-photon induced emission in several carcinoma cell 
lines along with long resident lifetime with a low dosage requirement, and demonstrated a 
strong NIR emission in Golgi apparatus enabling it for use in imaging and photodynamic 
therapy.50 
In 201 5, a cisplatin-linked europium-cyclen complex was introduced as a light -responsive 
antitumor agent. This modified structure controls the release of cisplatin by linear/two­
photon excitation in vitro. Photo-dissociation of cisplatin leads to detect Eu emission at 
6 1 5  nm upon excitation at 325 nm, allowing the real-time monitoring of the cisplatin 
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discharge. This allows use of the cisplatin-linked europium-cyclen complex as an 
antitumor chemotherapeutic agent (prodrug) as well as a luminescence imaging probe.51  
In 2017, a porphyrin moiety capable of killing tumor cells was presented as a multi-modal 
lanthanide-porphyrin PDT agent. Strong erbium NIR emission was observed at 654 run, 
7 1 5  nm, and 1 5 3 1  nm along with specific affinity for bladder cancer cells by specifically 
targeting the integrin avb3 isoform. The results obtained by flow cytometry and in vitro 
imaging proved the selective uptake of complexes by cancer and the ability to interrupt the 
growth of bladder cancer cells via specific binding to the "integrin avb3 isoform".52 
Lanthanide complexes have been synthesized to detect nucleic acid in such roles as 
heterogeneous DNA analysis, homogeneous assays, intercalation assays, real time PCR 
assays, and genotyping assays. 53 Eu(III) complexes have been used for many years in DNA 
analysis assays. Tb(III) and Eu(III) typically exhibit emission lifetimes in the millisecond 
range, therefore these long lifetimes are useful to detect biomolecules labeled with 
lanthanide ions with zero background measurements with higher sensitivities.54 Tuning of 
the emission wavelengths from 520-680 nm and lifetimes from 50-500 µs by introducing 
larger conjugation systems in the ligand of the lanthanide metal complexes has broadened 
the horizon of their applications as contrasting agents.34 
Dipicolinic acids (DPA) and its derivatives have been demonstrated intense Tb(III) 
emissions showing useful properties for immunoassays. Upon excitation at 800 nm, Eu(III) 
and Tb(Ul) derivatives of dipicolinic acid fuctionalized with polyoxyethylene pendant 
arms and terminal groups containing complexes show luminescence which is useful to 
use these as immune probes.55 As Lanthanides possess the ability to bind active sites of 
proteins and metalloproteins, there is a potential to use these ions to explore the 
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composition and structure of those biomolecules, by obtaining the data related to excitation 
and emission spectra.56 Tb(III)and Eu(III) are used for this application as they can replace 
Ca(II), Zn(II), Mg(II), Mn(II), Fe(II), and Fe(III) from some metalloproteins. 
For the treatment of treatment of age-related macular degeneration (AMD) and for 
atherosclerotic plaque in coronary heart disease, lutetium texaphyrin was tested as photo­
activated agent. 57 Furthermore, texaphyrins complexes were tested for photodynamic 
therapy as they showed emissions at longer wavelengths (700 nm) facilitating higher tissue 
penetration. For cancer treatment using radio- and chemo-sensitization applications, a Gd­
texaphyrin complex, motexafin gadolinium (MGd, Xcytrin) was tested based on its 
remarkable redox properties. 58 
1.5. Motivation 
To address the major shortcomes related to narrow excitation window, low emission 
efficiency, low solubility, poor functionality, low sensitivity, and selectivity due to 
autofluorescence arise from biological environments, and photobleaching by prevailing 
fluorescent materials, there is a thirst of introducing novel compounds to clinical trials and 
medical diagnosis purposes with higher functionality. To accomplish above mentioned 
goal, functionalization of BODIPY dyes to synthesize lanthanide complexes is a solution 
to come up with better emission efficiencies in NIR region with low background noise. The 
choice of BODIPY as the chromophore allows to excite the novel complexes in visible 
region, minimizing photobleaching. Functionalizing the BODIPY core with conjugated 
ligand binding group enhance the stable complex formation and energy transfer 
efficiencies. Therefore, research work has been done to synthesize novel BODIPY based 
DOT A and phenanthroline ytterbium complexes. 
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1 .6. Objectives 
Project 1 
• Synthesize and functionalization ofBODIPY based DOTA-ytterbium complexes 
./ Synthesize of parent BODIPY dye 
Project 2 
./ Functionalization with different lengths of alkyl chains on the 
meso position of the BODIPY core 
./ Combine the BODIPY derivative with DOT A moiety 
./ Characterization of final products via 1H NMR and X-ray 
crystallography data 
• Synthesize and functionalization of BODIPY based phenanthroline-ytterbium 
complexes 
./ Synthesize of parent BODIPY dye 
./ Synthesize of 5-amino-( 1 , 1 0-phenanthroline) 
./ Functionalization of the BODIPY core with phenanthroline ligand 
binding group 
./ Characterization of intermediates and final products via 1 H NMR 
and X-ray crystallography data 
• Photophysical studies of BODIPY based phenanthroline ytterbium complexes 
./ Record the absorption, excitation, emission spectra of 
intermediate and final products 
./ Obtain the quantum yield, lifetime for intermediate and final 
products 
./ Record the NIR emission of final lanthanide complexes 
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2.1. General 
2.1.1.  Materials 
CHAPTER 2 
EXPERIMENT AL 
All reagents and solvents were purchased from commercial sources and employed without 
further purification unless otherwise stated. The procedure includes analytical grade 
chemicals that were used as received. Dichloromethane, methanol, hexane, chloroform, 
acetonitrile, triethylamine, and toluene were purchased from Fisher Chemical Scientific. 
2,3-Dichloro-5,6-dicyano-1 ,4-benzoquinone (DDQ) was supplied by Biosynth 
International, Inc. Tetrahydrofuran (THF), dimethylformamide (DMF), deuterated 
chloroform, boron trifluoride diethyl etherate, 2,4-dimethyl-3-ethylpyrrole, 4-
hydroxybenzaldehyde, anhydrous K2C03, 1 ,2-dibromoethane and thiophosgene (CSCh) 
were purchased from ACROS Organics. Anhydrous Na2C03 was purchase from Fisher 
science education. 1,3-Dibromopropane, and 1 ,4-dibromobutane, were purchased from 
Tokyo Chemical Industry Co. Ltd. D03A was purchase from Areva Med.Company. 2-
Aminobenzaldehyde and 4-aminobenzaldehyde were purchased from Santa-Cruz 
Biotechnology Inc. 5-Amino- 1 , 1 0-phenanthroline was purchased from Aldrich. Acetone 
was purchased from Sherwin Williams. Nitrogen gas was supplied by Geno Welding 
(Mattoon, IL). Column chromatography was conducted using 70-230-mesh silica gel. 
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2.1.2. Instruments 
A 400 MHz Bruker Avance II-NMR spectrometer was used to obtain 1H NMR spectra, 
using ACROS Organics chloroform-d 99.8% D, containing 0.03% (v/v) TMS. NMR 
spectra were processed using Bruker's TopSpin software. The chemical shifts were 
reported in parts per million (ppm). For the signal splitting, the following abbreviations 
are used: s, singlet; d, doublet; t, triplet; m, multiplet; br, broad peaks; dd, doublet of 
doublets. UV-Vis absorption spectra were performed on a Cary 100 Series UV-Vis Dual 
Beam Spectrophotometer over a range of 200-800 nm. Steady state fluorescence spectra 
were obtained from FS5 fluorimeter (Edinburgh Instruments, Inc.). 
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2.2. Synthesis 
2.2.1. Project 1 Synthetic Route 
A synthetic overview for the synthesis of the dyes is illustrated below (Scheme 2.1.). The 
details of the synthesis are presented in sections 2.2. 1.3-2.2. 1 . 9. 
OH 
RH3 n• 2.3.• 
11•2JOW 
n•3RHS D•4Rlf6 
-l 
Scheme 2.1.  Synthesis o f  ytterbium complexes ofRH7, RH8, and RH9. 
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2.2. 1 . 1  Synthesis of RHl 
( (T-4 )-[ 4-[ (3 ,5-Dimethyl- l H-pyrrol-2-yl-KN)(3 ,5-dimethyl-2H-pyrrol-2-ylidene-
KN)methyl]phenolato ]difluoroboron) 
OH 
+ 2 O-
N H 
1. CH2Cl2, N2 atmosphere, r.t. 
2. BF30Et2 , 3h 
3. DDQ, l h  
4 .  NEt3 
5. BF30Et2 , 2h 
Figure 2.1. Synthesis of RHl 
OH 
This compound was synthesized according to a previously reported method.59 Under N2 
atmosphere, to a solution of 4-hydroxybenzaldehyde (0.243 g, 2.0 mmol) and 2,4-
dimethyl-l H-pyrrole (0.5 mL, 5.0 mmol) in 1 50.0 mL of CH2Ch, 0.5 mL Bf3·0Eti was 
added at room temperature. This solution was stirred overnight. Then 2,3-dichloro-5,6-
dicyano-1 ,4-benzoquinone (0.900 g, 4 mmol) was added and stirred for 1 hour. Next 
triethylamine (6.00 mL, 43.0 mmol) was added to the reaction mixture. After stirring the 
reaction mixture for 1 5  minutes, BFrOEti (8.00 mL, 32.0 mmol) was added to it and 
stirring was continued for 3 hours. Then the solvent was removed under vacuum and the 
black oily residue was purified using column chromatography on silica with CH2Ch. The 
isolated product was a bright orange solid with an orange fluorescence. Yield: 0. 1 34 g (0.4 
mmol, 1 9.8%). 1H NMR (400 MHz, CDCb): 8 = 7. 14  (d, 2Ha), 6.95 (d, 2Hb), 5.97 (s, 2H<l), 
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2.2.1.2. Synthesis of RH2 
((T-4)-[2-[[4-(3-bromopropoxy)phenyl](3,5-dimethyl-2H-pyrrol-2-ylidene-KN)methyl]-3, 
5-dimethyl-l H-pyrrolato-KN]difluoroboron) 
OH 
Cs,C03,DMF 
r.t,12 h 
Figure 2.2. Synthesis of RH2 
o� 
Br 
R H l  (0.272 g, 0.8 mmol) was dissolved in 50.0 mL of DMF and Cs2C03 ( l .02 g, 3 . 1 3  
mmol) was added to flask and stirring was continued for 1 5  minutes. Then 1 ,2-
dibromopropane (2.0 mL, 23. 1 mmol) was added to the reaction mixture. This mixture was 
stirred for 1 2  hours under N2 atmosphere at room temperature. Then the solvent was 
removed by vacuum and the orange crude product was purified using column 
chromatography on silica with CH2Ch. The isolated product was a bright orange solid with 
an orange fluorescence. Yield: 0.0 1 8  g (0.04 mmol, 1 0.0%). 1H NMR (400 MHz, CDCh): 
� = 7.20 (d, 2Ha), 7.04 (d, 2Hb), 5.98 (s, 2Hd), 4.35 (t, 2H�, 3.69 (t, 2Hg), 2.55 (s, 6Hc), 
1 .42 (s, 6Hc), 0.90 (m, 2Hh). 
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2.2.J.3. Synthesis of RH3 
((T-4)-[ 4-[ ( 4-ethyl-3,5-dimethyl- l H-pyrrol-2-yl-KN)( 4-ethyl-�,5-dimethyl-2H-pyrrol-2-
ylidene-KN)methyl]phenolato ]difluoroboron) 
OH 
+ 1b= 
N 
H 
I. CH2Cl2, N2 atmosphere, r.t. 
2. BF30Et2 , 3h 
3. DDQ, lh 
4. NEt3 
5. BF30Et2 , 2h 
Figure 2.3. Synthesis of RH3 
OH 
This compound was synthesized according to a previously reported method. 59 Under N2 
atmosphere, to a solution of 4-hydroxybenzaldehyde (0.487 g, 4.0 mmol) and 3-ethyl-2,4-
dimethyl-l H-pyrrole ( 1 . 1 0  mL, 8. 1 5  mmol) in 300.0 mL ofCH2Ch, 0.5 mL Bf3·0Etiwas 
added at room temperature. This reaction mixture was stirred overnight. Then 2,3-dichloro-
5,6-dicyano-1 ,4-benzoquinone ( 1 .80 g, 7.93 mmol) was added and stirred for 1 hour. Next 
triethylamine ( 1 2.00 mL, 86.0 mmol) was added to the reaction mixture. After stirring the 
reaction mixture for 1 5  minutes, Bf3.0Et2 (8.00 mL, 32.0 mmol) was added to it and 
stirring was continued for 3 hours. Then the solvent was removed under vacuum and the 
black oily residue was purified using column chromatography on silica with CH2Clz. The 
isolated product was a bright orange solid with an orange fluorescence. Yield: 0.3 1 0  g 
(0.782 mmol, 1 9.6%). 1 H  NMR (400 MHz, CDCb): 8 = 7. 12  (d, 2Ha), 6.95 (d, 2Hb), 2.52 
(s, 6Hf), 2.30 (q, 2Hd), 1 .34 (s, 6Hc), 0.98 (t, 6He) 
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2.2. 1.4. Synthesis ofRH4 
((T-4)-[2-[[4-(2-bromoethoxy)phenyl]( 4-ethyl-3,5-dimethyl-2H-pyrrol-2-ylidene-KN) 
methyl]- 4-ethyl-3,5-dirnethyl-l H-pyrrolato-KN]difluoroboron) 
OH 
1,2-Dibromocthanc 
K2C03, CH3CN 
80°C, Sh 
Figure 2.4. Synthesis of RH4 
O�Br 
RH3 (0.162 g, 0.41 mmol) was dissolved in 50.0 mL of CH3CN and anhydrous K2C03 
( 1 . 0 1  g, 7 . 3 1  mmol) was added to the flask and stirring was continued for 1 5  minutes. Then 
1 ,2-dibromoethane (2.0 mL, 23. 1  mmol) was added to the reaction mixture. This mixture 
was stirred for 5 hours under N2 atmosphere at 80°C. Then the solvent was removed by 
vacuum and the orange crude product was purified using column chromatography on silica 
with CH2Ch. The isolated product was a bright orange solid with an orange fluorescence. 
Yield: 0 . 127 g (0.25 mmol, 6 1 .0%). 1H NMR (400 MHz, CDCb): 8 = 7.20 (d, 2H3), 7.03 
(d, 2Hb), 4.36 (t, 2H&), 3.70 (t, 2Hh), 2.53 (s, 6Hr), 2.30 (q, 2Hd), 1 .32 (s, 6Hc), 0.98 (t, 6He). 
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2.2.1.5. Synthesis of RH5 
( (T-4 )-[2-[[ 4-(3-bromopropoxy)phenyl]( 4-ethyl-3 ,5-dimethyl-2H-pyrrol-2-ylidene-KN) 
methyl]- 4-ethyl-3 ,5-dimethyl- I H-pyrrolato-KN]difluoroboron) 
OH 
1,3-Dibromopropane 
K2co,. CH3CN 
80"C, Sh 
Figure 2.5. Synthesis of RH5 
o� 
Br 
RH3 (0. 1 6 1 g, 0.41 mmol) dissolved in 50.0 mL ofCH3CN and anhydrous K1C03 ( I .O J  g, 
7.31 mmol) were added to flask and stirring was continued for 1 5  minutes. Then 1 ,2-
dibromopropane (2.4 rnL, 23. l rnrnol) was added to the reaction mixture. This mixture was 
stirred for 5 hours under N1 atmosphere at 80°C. Then the solvent was removed by vacuum 
and the orange crude product was purified using column chromatography on silica with 
CH2Ch. The isolated product was a bright orange solid with an orange fluorescence. Yield: 
0. 1 10 g (0.21 mmol, 5 1 .2%). 1 H  NMR (400 MHz, CDCb): o = 7 . 1 8  (d, 2H3), 7.01 (d, 2Hb), 
4 . 17  (t, 2Hg), 3.65 (t, 2Hh), 2.53 (s, 6Hr), 2.37 (m, 2Hi), 2.30 (q, 2Hd), 1 .33 (s, 6Hc), 0.98 
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2.2.J.6. Synthesis of RH6 
((T-4)-(2-[[4-(4-bromobutoxy)phenyl]( 4-ethyl-3,5-dimethyl-2H-pyrrol-2-ylidene-KN) 
methyl]- 4-ethyl-3,5-dimethyl- l H-pyrrolato-KN]difluoroboron) 
OH 
I ,4·Dibromobutane 
K1C03, CH1CN 
80"C, Sh 
Figure 2.6. Synthesis of RH6 
RH3 (0.163 g, 0.41 mmol) was dissolved in 50.0 mL of CH3CN and anhydrous K1C03 
( l .06 g, 7.67 mmol) was added to flask and stirring was continued for 15  minutes. Then 
1 ,2-dibromobutane (2.0 mL, 16.8 mmol) was added to the reaction mixture. This mixture 
was stirred for 5 hours under N2 atmosphere at 80°C. Then the solvent was removed by 
vacuum and the orange crude solid was purified using column chromatography on silica 
with CH2Ch. The isolated product was a bright orange solid with an orange fluorescence. 
Yield: 0 . 126 g (0.24 mmol, 58.5%). 1H NMR (400 MHz, CDCb): 8 = 7. 17  (d, 2H3), 7.00 
(d, 2Hb), 4.08 (t, 2Hg), 3.52 (t, 2Hh), 2.53 (s, 6H\ 2.30 (q, 2Hd), 2 . 12  (m, 2Hi), 2.00 (m, 
2IP), 1 .33 (s, 6Hc), 0.98 (t, 6He). 
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2.2.J .7. Synthesis of RH7 
0�Br 
+ 
Figure 2.7. Synthesis of RH7 
0 
(°lo1Bu 
(N"'l 
0,..,.._.N N'>= 
�N-4uo 
0 
I �  1Bu0r( 
0 
D03A (0.185 g, 0.39 mmol) was dissolved in 50.0 mL of CH3CN. Then K2C03 (2.02 g, 
14.6 mol) was added to the reaction flask. Next RH4 (0.204 g, 0.41 mmol) was added to 
the reaction flask and stirred for one day at room temperature. Next day the solvent was 
removed and the orange color residue was purified using column chromatography on silica. 
At first CH2Ch was used as the solvent. Then CH2Ch: Methanol (300:20) was used to 
separate the target product. The isolated product was a bright orange solid with an orange 
fluorescence. Yield: 0. 1 50 g (0. 1 6  mmol, 41 .0%). 1H NMR (400 MHz, CDCh): o = 7 . 1 2  
(d, 2H3), 7.08 (d, 2Hb), 4.28 (t, 2Hg), 3. 1 8  (s, 2Hk), 3.07 (t, 2Hh), 2.91 (br, 16Hij), 2.52 (s, 
6Hr), 2.30 (q, 2Hd), l .40-1 .46 (m, 27H1), 1 .30 (s, 6Hc), 0.98 (t, 6Hc). 
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2.2.1.8. Synthesis of RH8 
O�Br 
+ 
Figure 2.8. Synthesis of RH8 
D03A (0.095 g, 0.20 mmol) was dissolved in 50.0 mL of CH3CN. Then K2C03 (2.01 g, 
1 4.6 mol) was added to the reaction flask. Next RHS (0. 125 g, 0.24 mrnol) was added to 
the reaction flask and stirred for one day at room temperature. Next day the solvent was 
removed and the orange color residue was purified using column chromatography on silica. 
At first CH2Ch was used as the solvent. Then CH2Ch: Methanol (300:20) was used to 
separate the target product. The isolated product was a bright orange solid with an orange 
fluorescence. Yield: 0.088 g (0.09 mmol, 45.0%). 1H NMR (400 MHz, CDCh): () = 7 . 16  
(d, 2Ha), 6.96 (d, 2Hb), 4.03 (t, 2Hg), 3.70- 3 . 10 (s, 2Hh), 3.70-2.84 (t, 2Hk), 3 .21-3 . 10 (br, 
l 6HiJ), 2.53 (s, 6Hf), 2.30 (q, 2Hd), 2.00-2.05 (m, 2Hm), 1 .44-1.49 (m, 27H1), 1 .32 (s, 6Hc), 
0.98 (t, 6He). 
53 
2.2. 1.9. Synthesis of RH9 
O�Br 
+ K2C03 • 
CH3CN r.t 
l day 
Figure 2.9. Synthesis of RH9 
D03A (0.089g, 0. 188 rnmol) was dissolved in 50.0 mL of CH3CN. Then K2C03 ( 1 .04 g, 
7.53 mot) was added to the reaction flask. Next RH6 (0. 1 25 g, 0.24 mmol) was added to 
the reaction flask and stirred for one day at room temperature. Next day the solvent was 
removed and the orange color residue was purified using column chromatography on silica. 
At first CH2Ch was used as the solvent. Then CH2Ch: Methanol (300:20) was used to 
separate the target product. The isolated product was a red solid with an orange 
fluorescence. Yield: 0 . 127 g (0.132 mmol, 70.2%). 1 H  NMR (400 MHz, CDCb): 8 = 7 . 16  
( d, 2H3), 6.97 ( d, 2Hb), 4.01 (t, 2Hg), 3.4 7 (t, 2Hh), 3.20-2.8 1 (s, 2Hk), 3.20-2.81 (br, 16Hij), 
2.53 (s, 6Hf), 2.30 (q, 2 Hd), 1 .79 (m, 2Hm), 1 .78 (m, 2H"), 1 .44-1.47 (m, 27H1), 1 .33 (s, 
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2.2.2. Project 2 Synthetic Route 
A synthetic overview for the synthesis of the dyes is illustrated below (Scheme 2.2). The 
details of the synthesis are presented in sections 2.2.2. 1-2.2. J. 7. 
Scheme 2.2. Project 2, synthesis of ytterbium complexes ofRH 1 2  and RH14 (Complex 1 
and Complex 2) 
SS 
2.2.2. 1. Synthesis of RHJO 
( (T-4 )-[ 4-[ ( 4-ethyl-3 ,5-dimethyl- l H-pyrrol-2-yl-t<N)( 4-ethyl-3 ,5-dimethyl-2H-pyrrol-2-
ylidene-t<N)meth yl ]-benzenamina to] di fluoroboron) 
+ 2'0= N H 
I. CH2Cl2. N1 atmosphere, r.t. 
2. BF30Eti , 3h 
3. DDQ, lh 
4. NEt3 
5. BF30Et2 . 2h 
Figure 2.10. Synthesis of RH I O  
This compound was synthesized according to a previously reported method.59 Under N2 
atmosphere, to a solution of 4-aminobenzaldehyde (0.244 g, 2.0 mmol) and 3-ethyl-2,4-
dimethyl- I H-pyrrole (0.6 mL, 4.4 mmol) in 300.0 mL of CH2Cb, 0.5 mL Bf 3·0Et2 was 
added at room temperature. This reaction mixture was stirred overnight. Then 2,3-dichloro-
5,6-dicyano-l ,4-benzoquinone (0.90 g, 3.86 mmol) was added and stirred for 1 hour. Next 
triethylamine (6.00mL, 43.0 mmol) was added to the reaction mixture. After stirring the 
reaction mixture for 1 5  minutes, 8f3.0Et2 (8.00 mL, 32.0 mmol) was added to it and 
stirring was continued for 3 hours. Then the solvent was removed under vacuum and the 
black oily residue was purified using column chromatography on silica with CH2Cb first 
and then with CH2Ch: Hexane ( 1 00: I 0). The isolated product was a bright orange solid 
with an orange fluorescence. Yield: 0.081 g (0.205 mmol, 10.25%). 1H NMR (400 MHz, 
CDCh): o = 7.74 (d, 2H3), 7.55 (d, 2Hb), 2.54 (s, 6H�, 2.33 (q, 2Hd), 1 .33 (s, 6Hc), 0.99 (t, 
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2.2.2.2. Synthesis of RHJ I 
(5-Isothiocyanato-l ,  1 0-phenanthroline) 
CSC12, Na2C03 
Acetone, r.t. ., N2 atmosphere 
Figure 2.1 1. Synthesis ofRH l 1 
This compound was synthesized according to a previously reported method.60 To a 
suspension of 5-amino- 1 , 1 0-phenanthroline (0.204g, 1 .0 mmol) in 100.0 mL of acetone, 
Na2C03 (0.44g, 4 . 1  mmol) was added. To the same reaction mixture CSCh (0.35 mL, 4.57 
mmol) was added and stirring was continued at ambient temperature for 22 �ours under N2 
atmosphere. Then the solvent was removed under reduced pressure. A pale-yellow solid 
was obtained. Yield: 0.201g (84.8%). 1H NMR (400 MHz, CDCb): 8 = 9.33 (dd, l Ha), 
9.28 (dd, lHh), 8.62 (dd, l Hc), 8.28 (dd, l Hr), 7.82 (s, l Hc), 7.80 (dd, l Hb), 7.72 (dd, I Hg). 
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2.2.2.3. Synthesis of RH I 2 
(N- 1 ,  1 O-phenanthrolin-5-yl-[ ((T-4)-[ 4-[( 4-ethyl-3,5-dimethyl- l H-pyrrol-2-yl-KN)( 4-
ethyl-3,5-dimethyl-2H-pyrrol-2-ylidene-KN)methyl]-N-phenyl]difluoroboron)thiourea) 
SCN 
+ 
Acetone, ,. r.t, 3 days 
Figure 2.12. Synthesis of RH 1 2  
This compound was synthesized according to a previously reported method.61 To a 
suspension of RHlO (0.057g, 0. 1 4  mmol) in 50.0 mL of acetone, RH I 1 (0.053g, 0.22 
mmol) was added. The reaction mixture was further stirred at ambient temperature for three 
days. The reaction progress was monitored with TLC. After three days, the solvent was 
removed and the final product purified on a column chromatography (silica gel, CH2Ch: 
CH30H = 1 0 : 1 ,  v/v) to give BDP as bright orange powder. Yield: 0.058 g, 65.5%. 1H NMR (400 
MHz, CDCb): 9 . 12  (dd, l Hi), 9.0 1 (dd, 1 H0), 8.54 (dd, lHm), 8.23 (dd, l Hk), 7.99 (s, 1 H1), 
7.75 (dd, I H"), 7.73 (dd, l Hj), 7.67 (d, 2H3), 7.65 (d, 2Hb), 2.52 (s, 6H�, 2.29 (q, 2Hd), l .30 
(s, 6Hc), 0.96 (t, 6He). 
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2.2.2.4. Synthesis of RHI 3 
( (T-4 )-(2-( ( 4-ethyl-3 ,5-dimethyl- l H-pyrrol-2-yl-KN)( 4-ethyl-3 ,5-dimethyl-2H-pyrrol-2-
ylidene-KN)methyl]-benzenaminato ]difluoroboron) 
!. Cfi:iCl2. N2 atmosphere, r.t. 
2. BF;f?Et2, 3h 
3. DDQ,lh 
4.NE.t:3 
5. BFJ0Eli . 2h 
Figure 2.13. Synthesis of RHI3 
This compound was synthesized according to a previously reported method.59 Under N2 
atmosphere, to a solution of 2-aminobenzaldehyde (0.244 g, 2.0 mmol) and 3-ethyl-2,4-
dimethyl-I H-pyrrole (0.6 mL, 4.4 mmol) in 300.0 mL of CH2Ch, 0.5 mL Bf 3.0Eti was 
added at room temperature. This reaction mixture was stirred for overnight. Then 2,3-
dichloro-5,6-dicyano-l ,4-benzoquinone (0.90 g, 3.86 mmol) was added and stirred for 1 
hour. Next triethylamine (6.00mL, 43.0 mmol) was added to the reaction mixture. After 
stirring the reaction mixture for 1 5  minutes, Bf3·0Eti (8.00 mL, 32.0 mmol) was added to 
it and stirring was continued for 3 hours. Then the solvent was removed under vacuum and 
black oily residue was purified using column chromatography on silica with CH2Ch first 
and then with CH2Ch: Hexane ( 100: 10). The isolated product yielded as a bright orange 
solid with an orange fluorescence. Yield: 0.072 g, (0. 1 8  mmol, 9 . 1  %). 1H NMR ( 400 MHz, 
CDCb): o = 7.25 (d, l Ha), 7.03 (d, l Hb), 6.88 (t, l Hc), 6.7 (d, I Hd), 2.55 (s, 6Hh), 2.33 (q, 
3 Hr), 1 .4 1  (s, 6He), 1 .03 (t, 6Hg). 
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2.2.2.5. Synthesis of RHJ4 
(N- 1 ,  1 O-phenanthrolin-5-yl-[ ((T-4)-[2-(( 4-ethyl-3,5-dimethyl- l H-pyrrol-2-yl-KN)( 4-
ethyl-3,5-dimethyl-2H-pyrrol-2-ylidene-KN)methyl]-N-phenyl]difluoroboron)thiourea) 
Acetooe, 
r.t, 3 days 
Figure 2.14. Synthesis of R H 1 4  
This compound was synthesized according to a previously reported method.61 To a 
suspension of RH l 3  (0.1 5g, 0.38 mmol) in 50.0 mL of acetone, RH l l (O.l Og, 0.42 mmol) 
was added. The reaction mixture was further stirred at ambient temperature for three days. 
The reaction progress was monitored with TLC. After three days, the solvent was removed 
and the final product was purified on a column chromatography (silica gel, CH2Ch: 
CH30H = 10 :  1 ,  v/v) to give BDP as bright orange powder. Yield: 0.042 g, 1 7.5%. 1H NMR 
(400 MHz, CDCb): 8 = 9.22 (t, 2HP,q), 8.40 (dd, l Hi), 8.35 (dd, 1 H0), 8.28 (dd, l Hm), 7.77 
{s, l Hk), 7.69 (m, 1 H0), 7.68 (m, l Hj), 7.62 (s, 1 H1), 7.53 (d, l H3), 7.49 (s, l Hb), 7.38 (dd, 
l Hc), 7 . 1 2  (dd, l Hd), 2.30 (s, 6Hh), 2.0 1 (q, 2Hr), 1 .05 (s, 6He), 0.76 (t, 6Hg). 
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2.2.2.6. Synthesis of Complex 1 
Figure 2.15. Synthesis of Complex I 
To a suspension of RH1 2  (0.0 1 0  g, 0.016 mmol) m 25.0 mL toluene, 
[Yb(TPP)(OAc)(MeOH)2] (0.014 g, 0.0 1 5  mmol) was added. The reaction mixture was 
stirred at ambient temperature overnight. The solvent was removed and the final product 
was purified on a column chromatography (silica gel, first with CH2Ch: then CH30H = 100:1, 
v/v) to give dark purple powder. Yield: 0.023 g, 86. l l %. 
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2.2.2. 7. Synthesis of Complex 2 
Figure 2.16. Synthesis of Complex 2 
To a suspension of RH14 (0.004 g, 0.006 mmol) m 25.0 mL toluene, 
[Yb(TPP)(OAc)(MeOH)2] (0.006 g, 0.006 mmol) was added. The reaction mixture was 
stirred at ambient temperature, overnight. The solvent was removed and the final product 
was purified on a column chromatography (silica gel, first with CH2Ch: then CH30H = 
l 00: 1 ,  v/v) to give dark purple powder. Yield: 0.005 g, 87.68%. 
2.3. Photophysical measurements 
2.3.1 UV-VIS Absorption spectra in solutions 
Absorption spectra for synthesized ligands and complexes were measured using HP 
Agilent 5439 UV-Visible spectrometer with 1 .0 cm quartz cell. The stock solution 
concentration of the samples was 2.0x I 0-4 M, and 20 µL of each was added to 2.5 mL of 
dichloromethane in a 1 .0 cm quartz cuvette. The spectra were recorded from 400-800 nm. 
The final concentration of each dye was l .6x 1 0  6 M. The final concentr�tion for each dye 
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in the cuvette (C2) was determined fust by determining the concentration of the stock 
solution (M (stock)= C 1 (stock)) using the molarity formula, 
M (stock)= C1 (stock) = Moles of dye/ Liters of solvent 
where C1 is the concentration of the stock solution, V1 is the volume of the stock solution 
added, and V2 is the total volume in the cuvette. 
The molar extinction coefficient was calculated for each ligand and complex using Beer­
Lambert law, 
A = ccl 
where A is the maximum absorption of ligand or the complex, E is absorption coefficient, 
c is the analyte concentration and l is the path length of the incident light. 
2.3.2. Fluorescence Spectra 
2.3.2.J. Excitation and Emission Spectra 
Excitation and emission spectra for RH 1 2  and RH 1 4  were recorded using steady-state 
excitation with a xenon arc lamp. Both RH 1 2  and RH14  ligands were excited at 500 nm 
and data was collected from 450-575 nm range to obtain the emission spectra. The 
excitation spectra were recorded by setting the emission at 540 nm and spectra were 
recorded from 5 1 0-700 range. Concentrations of both ligands were kept the same as 
l .6x 1 o-6 M in the cuvette. 
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2.3.2.2. Quantum yield measurements 
The quantum yield of ligands was evaluated according to the below equation. 
0x = 0sT r Gradx] r�12 GradsTe nsT 
where 0x is the fluorescence quantum yield of compound, 0sT is the standard fluorescence 
quanttim yield (0x= 0.95, A.ex = 480 nm for rhodamine 6G), Gradx is the gradient from the 
plot of the integrated fluorescence intensity vs absorbance of ligands with different 
concentrations, GradsT is the gradient from the integrated fluorescence intensity vs 
absorbance with different rhodamine 6G standard in ethanol, nx and nsT are refractive 
indexes of the solvents used to dissolve ligands and standard rhodamine 6G samples, 
respectively. Initial concentration of rhodamine 6G was 3 .34 x 104 M. A stock solution of 
rhodamine 6G with 3.34 x 1 04 M concentration (in ethanol) was prepared and 0, 50, 100, 
1 50, 1 85 and 225 µL of it was added to 2.5 mL of CH2Ch in a cuvette. For each sample, 
both absorption (400-800 nm range) and fluorescence emission spectra (excited at 480 nm, 
emission measured at 500-700 nm range, 1 repeat, 0.5 dwell time, 1 .0 emission and 
excitation bandwidth) were recorded separately. Standard 1 0  mm path length fluorescence 
cuvette was used for the measurements so that above mentioned volumes were chosen 
below 0. 1  absorbance at 480 nm. 
The quantum yields of RH12  and RH14 ligands were measured using above method. A 
stock solution ofRH 1 2  with 2 . 1 6  x 1 04 M  concentration (20.00 mL in CH2Ch) was used 
to determine the quantum yield. 10, 20, 40, 60, 80, 90 µL volumes from the stock solution 
were added to 2.5 mL of CH2Ch in a fluorescence cuvette. RH1 4  with 1 .93 x 1 0·4 M 
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concentration stock solution (20.00 mL in CH2Ch) was prepared and 20, 45, 70, 95, 120 
µL were added from the stock solution into 2.5 mL of CH2Ch in a fluorescence cuvette 
and absorption and emission spectra were recorded with above mentioned parameters. 
Using an integrated fluorescence intensity vs absorbance graphs for standard rhodamine 
6G and ligands, quantum yields were calculated substituting the gradients of the graphs to 
above mentioned equation. 
2.3.3. Lifetime measurements 
2.3.3.J. Lifetime measurement in the visible region 
Luminescence decay curves were generated using pulsed laser excitation by a laser diode 
EPL 375 (Edinburgh Instruments, Inc) with 375 nm light source. Decay curves of the 
sample in the visible region were obtained by a time-correlated single photon counting 
technique (TCSCT). The lifetimes were measured by exponential fitting of the 
deconvoluted decay data and tail fitting of the data for visible emission. The lifetime of 
RH 1 2  was measured at 537 nm while RH14 lifetime was measured at 549 nm. 
2.3.3.2. Lifetime measurement in the NIR region 
NIR decay curves were acquired using an optical parametric oscillator (OPTEK Opelette) 
as an excitation source. NIR emission was detected using a 0.3 m flat field monochromator 
(Jobin Yvon TRIAX 320) equipped with a NIR-sensitive photomultiplier tube (Hamamatsu 
R2658P). 
2.3.4 Spectroscopic titration 
The spectroscopic titration curves in the visible and NIR region were obtained by titrating 
RH12  and RH14  solutions with [Yb(TPP)(OAc)(MeOH)2] solution in CH2Ch to 
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understand the stoichiometry of the ligand and Yb(III) ion. The initial concentration of 
[Yb(TPP)(OAc)(MeOH)2] was 2.34 x 10-4 M. The initial concentrations of RH 1 2  and 
RH 1 4  were 2. 1 6  x 1 0-4 M and 1 .93 x 1 0-4 M in CH2Ch respectively. The titrations were 
carried out until the molar ratio of Yb(III) ions to ligand becomes 1 :  I .  For both ligands 
spectroscopic titrations were done in two different methods. First the stoichiometry was 
determined, titrating the ligand ( 100 µL from the stock solution of ligand was added to 2.5 
mL of CH2Ch in a cuvette) by Yb(III) ions, by adding 0, 20, 40, 60, 80, 100 µL from the 
stock solution. Secondly, back titrations were done, titrating Yb(III) ions ( 1 00 µL from the 
stock solution of [Yb(TPP)(OAc)(MeOH)2] was added to 2.5 mL of CH2Ch in a cuvette) 
with the ligand, by adding 0, 20, 40, 60, 80, 100 µL from the stock solutions of RH 1 2  and 
RH 14.  These two approaches were used to confirm the stoichiometry between the ligand 
and the Yb(III) ion in both complexes. 
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3.1. Characterization 
3.1.1. NMR Spectroscopy 
CHAPTER 3 
RESULTS AND DISCUSSION 
3. 1 . 1 . 1. 1H NMR of Compound RHJ 
OH 
1H NMR (400 MHz, CDCb): 8 = 7 . 14  (d, 2H8), 6.95 (d, 2Hb), 5.97 (s, 2Hd), 2.55 (s, 6He), 
1 .44 (s, 6Hc). 
The 1 H  NMR spectrum for RHl  is illustrated in the appendix (Figure A. l ). Five major 
peaks were produced. The phenol substituent's aromatic protons, labeled a and b, resulted 
in the most deshielded peaks at 7 . 14  ppm and 6.95 ppm, respectively. The two aromatic 
protons on the pyrrole groups, labeled d, produced a singlet at 5.97 ppm. The methyl groups 
bound to the pyrrole adjacent to the nitrogen atoms, labeled e, produced a singlet at 2.55 
ppm. The second set of methyl groups on the BODIPY core, labeled c, appeared as a singlet 
at 1 .44 ppm. 
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3.1.1.2. 1H NMR of Compound RH2 
f I o� 
h 
e 
1H NMR (400 MHz, CDCb): 8 = 7.20 (d, 2H3), 7.04 (d, 2Hb), 5.98 (s, 2Hct), 4.35 (t, 2Hf), 
3.69 (t, 2Hg), 2.55 (s, 6He), 1 .42 (s, 6Hc), 0.90 (m, 2Hh) 
The 1H NMR spectrum for RH2 is illustrated in the appendix (Figure A.2). Eight major 
peaks were produced. The phenol substituent's aromatic protons, labeled a and b, resulted 
in the most deshielded peaks at 7.20 ppm and 7.04 ppm, respectively. The two aromatic 
protons on the pyrrole groups, labeled d, produced a singlet at 5.98 ppm. Protons in the 
three-carbon alkyl chain labeled as f, g and h appeared at 4.35 ppm, 3.69 ppm and 0.90 
ppm respectively. Two triplets were observed corresponding to -CH2 protons bound to 
oxygen and bromine which are appeared more downfield due to the neighboring electro-
negative atoms. The methyl groups bound to the pyrrole adjacent to the nitrogen atoms, 
labeled e, produced a singlet at 2.55 ppm. The second set of methyl groups on the BODIPY 
core, labeled c, appeared as a singlet at 1.42 ppm. 
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3. l. l.3. 1H NMR ofCompoundRH3 
OH 
e 
1H NMR (400 MHz, CDCb): 8 = 7 . 1 2  (d, 2H3), 6.95 (d, 2Hb), 2.52 (s, 6Hr), 2.30 (q, 3H<l), 
1 .34 (s, 6Hc), 0.98 (t, 6He). 
The 1H NMR spectrum for RH3 is illustrated in the appendix (Figure A.3). Six major peaks 
were produced. The phenol substituent's aromatic protons, labeled a and b resulted in the 
most deshielded peaks at 7 . 1 2  ppm and 6.95 ppm, respectively. The methyl groups bound 
to the BODIPY core adjacent to the nitrogen atoms, labeled as f, experienced a downfield 
shift to 2.52 ppm. The quartet at 2.30 ppm corresponds to the -CH2 in the ethyl group bound 
to BODIPY core. At 1 .34 a singlet appeared which corresponds to the other methyl group 
in the BODIPY core. The most shielded -CH3 protons in the ethyl group bound to BODIPY 
core appeared at 0.98 ppm. 
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3. 1. 1.4. 1H NMR of Compound RH4 
g 
e 
1H NMR (400 MHz, CDCh): 8 = 7.20 (d, 2Ha), 7.03 (d, 2Hb), 4.36 (t, 2Hg), 3.70 (t, 2Hh), 
2.53 (s, 6Hr),  2.30 (q, 3Hd), 1 .32 (s, 6Hc), 0.98 (t, 6He). 
The 1 H NMR spectrum for RH4 is illustrated in the appendix (Figure A.4). Eight major 
peaks were produced. The phenol substituent's aromatic protons, labeled a and b resulted 
in the most deshielded peaks at 7.20 ppm and 7.03 ppm, respectively. The two-carbon alkyl 
chain linked to the phenolic group produced two signals. One signal with a triplet was 
observed at 4.36 ppm corresponding to -CH2 protons bound to oxygen and the other one 
is at 3. 70 ppm which is bound to the bromine atom in the other end. The methyl groups 
bound to the BODIPY core adjacent to the nitrogen atoms, labeled as f, experienced a 
downfield shift to 2.53 ppm. The quartet at 2.30 ppm corresponds to the -CH2 in the ethyl 
group bound to BODIPY core. At 1.32 ppm, a singlet appeared which corresponds to the 
other methyl group in the BODIPY core. The most shielded -CH3 protons in the ethyl 
group bound to BODIPY core appeared at 0.98 ppm. 
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3.1. 1.5. 1H NMR of Compound RH5 
1H NMR (400 MHz, CDCb): o = 7 . 18  (d, 2Ha), 7.01 (d, 2Hb), 4 . 17  (t, 2Hg), 3.65 (t, 2Hh), 
2.53 (s, 6Hf), 2.37 (m, 2Hi), 2.30 (q, 3Hd), 1 .33 (s, 6Hc), 0.98 (t, 6He). 
The 1H NMR spectrum for RH5 is illustrated in the appendix (Figure A.5). Nine major 
peaks were produced. The phenol substituent's aromatic protons, labeled a and b resulted 
in the most deshielded peaks at 7 . 18  ppm and 7.01 ppm, respectively. The three-carbon 
alkyl chain l inked to the phenolic group produces three signals. One signal with a triplet 
was observed at 4 . 17  ppm corresponding to -CH2 protons bound to oxygen and the other 
one is at 3.65 ppm which is bound to the bromine atom in the other end. The middle two 
protons in the three-carbon alkyl chain appeared at 2.37 ppm. The methyl groups bound to 
the BODIPY core adjacent to the nitrogen atoms, labeled as f, experienced a downfield 
shift to 2.53 ppm. The quartet at 2.30 ppm corresponds to the -CH2 in the ethyl group bound 
to BODIPY core. At 1.33 ppm, a singlet appeared which corresponds to the other methyl 
group in the BODIPY core. The most shielded -CH3 protons in the ethyl group bound to 
BODIPY core appeared at 0.98 ppm. 
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3. 1. 1.6. 1H NMR of Compound RH6 
e 
f 
g j o�Br 
i h 
1 H  NMR (400 MHz, CDCb): 8 = 7. 1 7  (d, 2Ha), 7.00 (d, 2Hb), 4.08 (t, 2H&), 3.52 (t, 2Hh), 
2.53 (s, 6Hr), 2.30 (q, 3 Hd), 2. 1 2  (m, 2Hi), 2.00 (m, 2Hi), 1 .33 (s, 6Hc), 0.98 (t, 6He). 
The 1 H NMR spectrum for RH6 is i llustrated in the appendix (Figure A.6). Ten major peaks 
were produced. The phenol substituent's aromatic protons, labeled a and b resulted in the 
most deshielded peaks at 7 . 17  ppm and 7.00 ppm, respectively. The four-carbon alkyl chain 
linked to the phenolic group produced four signals. One signal with a triplet was observed 
at 4.08 ppm corresponding to -CH2 protons bound to oxygen and the other one is at 3.52 
ppm which is bound to the bromine atom in the other end. The other four protons in the 
four-carbon alkyl chain appeared at 2.12 ppm and 2.00 ppm. The methyl groups bound to 
the BODIPY core adjacent to the nitrogen atoms, labeled as f, experienced a downfield 
shift to 2.53 ppm. The quartet at 2.30 ppm corresponds to the -CH2 in the ethyl group bound 
to BODIPY core. At 1 .33 ppm, a singlet appeared which corresponds to the other methyl 
group labeled as c in the BODIPY core. The most shielded-CH3 protons in the ethyl group 
bound to BODIPY core appeared at 0.98 ppm. 
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3. 1. 1. 7. / H NMR of Compound RH7 
1 H NMR (400 MHz, CDCb): 8 = 7. 1 2  (d, 2Ha), 7.08 (d, 2Hb), 4.28 (t, 2Hg), 3 . 1 8  (t, 2Hk), 
b . . f d I 3.07 (t, 2H ), 2.91 (br, 1 6H1J), 2.52 (s, 6H ), 2.30 ( q, 3H ), 1 .40- 1 .46 (s, 27H ), 1 .30 (s, 
6Hc), 0.98 (t, 6He). 
The 1 H  NMR spectrum for RH7 is illustrated in the appendix (Figure A.7). The phenol 
substituent's aromatic protons, labeled a and b resulted in the most deshielded peaks at 
7 . 1 2  ppm and 7 .08 ppm, respectively. The two-carbon alkyl chain linked to the phenolic 
group produced two signals. One signal with a triplet was observed at 4.28 ppm 
corresponding to -CH2 protons bound to oxygen and the other one is at 3.07 ppm which 
bound to the nitrogen atom in the DOT A moiety. The other protons in the DOT A moiety 
appeared at 3 . 18  ppm, 2.91 ppm and 1 .40-1.46 ppm labeled as k, i, j and I .  The methyl 
groups bound to the BODIPY core adjacent to the nitrogen atoms, labeled as f, experienced 
a downfield shift to 2.52 ppm. The quartet at 2.30 corresponds to the -CH2 in  the ethyl 
group bound to BODIPY core labeled as d. At 1 .30 ppm, a singlet appeared which 
corresponds to the other methyl group in the BODIPY core labeled as c. The most shielded 
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-CH3 protons in the ethyl group bound to BODIPY core appeared at 0.98 ppm represented 
as e. 
3. 1 . 1.8. 1H NMR of Compound RHB 
1H NMR (400 MHz, CDCb): o = 7 . 1 6  (d, 2Ha), 6.96 (d, 2Hb), 4.03 (t, 2Hg), 3.70- 3 . 10  (t, 
2Hh), 3.70-2.84 (t, 2Hk), 3.21-3. 1 0  (br, 16Hij), 2.53 (s, 6Hr), 2.30 (q, 3Hd), 2.00 (m, 2Hm), 
1 .44-1 .49 (s, 27H1), 1 .32 (s, 6Hc), 0.98 (t, 6He). 
The 1H NMR spectrum for RH8 is illustrated in the appendix (Figure A.8). The phenol 
substituent's aromatic protons, labeled a and b resulted in the most deshielded peaks at 
7 . 1 6  ppm and 6.96 ppm, respectively. The three-carbon alkyl chain linked to the phenolic 
group produced three signals. One signal with a triplet was observed at 4.03 ppm 
corresponding to -CH2 protons bound to oxygen and the other one is at 3.7-3.10 ppm range 
which bound to the nitrogen atom in the DOT A moiety. The more shielded protons between 
g and h protons labeled as m, appeared at 2.0 ppm as a multiplet. The other protons in the 
DOTA moiety appeared at 3 .70-2.84 ppm, 3.2 1-3. 10  ppm range and 1 .40-1 .46 ppm labeled 
as k, i ,j and l which are quite difficult to assign due to peak overlapping. The methyl groups 
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bound to the BODIPY core adjacent to the nitrogen atoms, labeled as f, experienced a 
downfield shift to 2.53 ppm. The quartet at 2.30 corresponds to the -CH2 in the ethyl group 
bound to BODIPY core labeled as d. At 1 .32 ppm, a singlet appeared which corresponds 
to the other methyl group in the BODIPY core labeled as c. The most shielded -CH3 
protons in the ethyl group, bound to BODIPY core appeared at 0.98 ppm represented as e. 
3 .1 . J .9. 1 H NMR of Compound RH9 
1 H  NMR (400 MHz, CDCb): o = 7. 1 6  (d, 2H3), 6.97 (d, 2Hb), 4.01 (t, 2Hg), 3.47 (t, 2Hh), 
3.20-2.81 (t, 2Hk), 3.20-2 .8 1  (br, 16Hij), 2.53 (s, 6H�, 2.30 (q, 3Hct), l .79 (m, 2Hm), 1 .78 
(m, 2H"), 1 .44-1 .47 (s, 27H1), 1 .33 (s, 6Hc), 0.98 (t, 6He). 
The 1 H  NMR spectrum for RH9 is illustrated in the appendix (Figure A.9). The phenol 
substituent's aromatic protons, labeled a and b resulted in the most deshielded peaks at 
7. 16  ppm and 6.97 ppm, respectively. The four-carbon alkyl chain linked to the phenolic 
group produced four signals. One signal with a triplet was observed at 4.01 ppm 
corresponding to -CH2 protons bound to oxygen and the other one is at 3.47 ppm which 
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bound to the nitrogen atom in the DOTA moiety. More shielded four protons between g 
and h protons labeled as m and n appeared at 1 .  79 and 1 .  78 respectively as multiplets. The 
other protons in the DOTA moiety appeared at 3.20-2.81 ppm, and 1 .40-1 .46 ppm labeled 
as k, i, j, and I. The methyl groups bound to the BODIPY core adjacent to the nitrogen 
atoms, labeled as f, experienced a downfield shift to 2.53 ppm. The quartet at 2.30 
corresponds to the -CH2 in the ethyl group bound to BODIPY core labeled as d. At 1 .33 
ppm, a singlet appeared which corresponds to the other methyl group in the BODIPY core 
labeled as c. The most shielded -CH3 protons in the ethyl group bound to BODIPY core 
appeared at 0.98 ppm represented as e. 
3. 1.1 . 10. 1H NMR a/Compound RHJO 
1H NMR (400 MHz, CDCb): o = 7.74 (d, 2Ha), 7.55 (d, 2Hb), 2.54 (s, 6Hr), 2.33 (q, 3H<l), 
1 .33 (s, 6Hc), 0.99 (t, 6He). 
The 1 H NMR spectrum for RH I O  is illustrated in the appendix (Figure A. l 0). Six major 
peaks were produced. The phenyl protons, labeled a and b resulted in the most deshielded 
peaks at 7.74 ppm and 7.55 ppm, respectively. The methyl groups bound to the BODIPY 
core adjacent to the nitrogen atoms, labeled as f, experienced a downfield shift to 2.54 ppm. 
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The quartet at 2.33 ppm corresponds to the -CH2 in the ethyl group bound to BODIPY core. 
At 1 .33 ppm, a singlet appeared which corresponds to the other methyl group in the 
BODIPY core. The most shielded -CH3 protons in the ethyl group labeled as e, bound to 
BODIPY cum appeared at 0.99 ppm. 
3. 1 . 1 . 11. 1H NMR a/Compound RH11 
e f 
I 
h 
1 H NMR (400 MHz, CDCb): 8 = 9.33 (dd, l H3), 9.28 (dd, l Hh), 8.62 (dd, l Hc), 8.28 (dd, 
I H�, 7.82 (s, l He), 7.80 (dd, l Hb), 7.72 (dd, I Hlt). 
The 1H NMR spectrum for RHI 1 is illustrated in the appendix (Figure A. 1 1  ). Seven signals 
were observed in this spectrum corresponding to protons in 2-9 positions in 1 ,  10-
phenanthroline. The most deshielded protons were observed at 9.33 ppm and 9.28 ppm 
represent 2 and 9 positions of phenanthroline. These are closer to the nitrogen atoms 
present in the phenanthroline group. Protons labeled as c and f were the next most 
deshielded protons corresponding 4 and 7 positions of the phenanthroline group appeared 
at 8.62 and 8.28. A singlet appeared at 7 .82 ppm labeled as e corresponds to the proton 
closer to -NCS group. Two protons in 3 and 8 positions of phenanthroline labeled as b and 
g appeared at 7.80 ppm and 7.72 ppm respectively. 
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3. 1. 1. 12. 1H NMR of Compound RH12 
I 
1 H  NMR (400 MHz, CDCh): 9 . 12  (dd, ! Hi), 9.01 (dd, 1 H0), 8.54 (dd, l Hm), 8.23 (dd, I Hk), 
7.99 (s, l H1), 7.75 (dd, l H"), 7.73 (dd, I Hj), 7.67 (d, 2H3), 7.65 (d, 2Hb), 2.52 (s, 6H\ 2.29 
(q, 3Hd), 1 .30 (s, 6Hc), 0.96 (t, 6Hc). 
The 1 H  NMR spectrum for RH 1 2  is illustrated in the appendix (Figure A . 1 2). Thirteen 
major peaks were produced. Seven signals were observed in this spectrum corresponding 
to protons in 2-9 positions in I ,  1 0-phenanthroline. The most deshielded protons were 
observed at 9. 12  ppm and 9.01 ppm represent 2 and 9 positions of phenanthroline labeled 
as i and o in the spectrum. Protons labeled as m and k were the next most deshielded protons 
corresponding 4 and 7 positions of the phenanthroline group appeared at 8.54 ppm and 
8.23 ppm respectively. A singlet appeared at 7.82 ppm labeled as 1 corresponds to the 
proton closer to -NH group in the bridge between the BODIPY core and the phenanthroline 
group. Two protons in 3 and 8 positions of phenanthroline labeled as n and j appeared at 
7.75 ppm and 7.73 ppm respectively. The phenyl protons, labeled a and b resulted in the 
downfield at 7 .67 ppm and 7 .65 ppm, respectively. The methyl groups bound to the 
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BODIPY core adjacent to the nitrogen atoms, labeled as f, experienced a downfield shift 
to 2.52 ppm. The quartet at 2.29 ppm corresponds to the -CH2 in the ethyl group bound to 
BODIPY core. At 1 .30 ppm, a singlet appeared which corresponds to the other methyl 
group in the BODIPY core labeled as c in the spectrum. The most shielded -CH3 protons 
in the ethyl group labeled as e bound to BODIPY core appeared at 0.96 ppm. 
3. I. l. I 3. 1 H NMR of Compound RH 13 
b 
1H NMR (400 MHz, CDCb): o = 7.25 (d, l Ha), 7.03 (d, l Hb), 6.88 (t, l Hc), 6.7 (d, l Hd), 
2.55 (s, 6Hh), 2.33 (q, 3H�, 1 .4 1  (s, 6He), 1.03 (t, 6Hg). 
The 1H NMR spectrum for RH13  is illustrated in the appendix (Figure A . 1 3) .  Eight major 
peaks were produced. The phenyl protons, labeled a, b, c, and d resulted in the most 
deshielded peaks at 7.25 ppm, 7.03 ppm, 6.88 ppm, and 6.7 ppm respectively. The methyl 
groups bound to the BODIPY core adjacent to the nitrogen atoms, labeled as f, experienced 
a downfield shift to 2.55 ppm. The quartet at 2.33 ppm corresponds to the -CH2 in the ethyl 
group bound to BODIPY core. At 1 .4 1  ppm, a singlet appeared which corresponds to the 
other methyl group in the BODIPY core. The most shielded -CH3 protons in the ethyl 
group, bound to BODIPY core appeared at 1 .03 ppm. 
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3.1.1. 14. 1H NMR of Compound RH14 
i 
k 
j 
h 
1 H  NMR (400 MHz, CDCb): o = 9.22 (t, 2HM), 8.40 (dd, I Hi), 8.35 (dd, I H0), 8.28 (dd, 
l Hm), 7.77 (s, l Hk), 7.69 (m, l H"), 7.68 (m, l Hj), 7.62 (s, 1 H1), 7.53 (d, l H3), 7.49 (s, l Hb), 
7.38 (dd, I He), 7 . 12  (dd, l Hd), 2.30 (s, 6Hh), 2.01 (q, 3H1, 1.05 (s, 6He), 0.76 (t, 6Hg). 
The 1 H  NMR spectrum for RH 1 4  is illustrated in the appendix (Figure A.14). Sixteen major 
peaks were produced. The most deshielded protons were observed at 9.22 ppm 
corresponding to two -NH groups present in the ligand. Seven signals were observed in 
this spectrum corresponding to protons in 2-9 positions in l ,  1 0-phenanthroline. The 
deshielded protons observed at 8.40 ppm and 8.35 ppm represent 2 and 9 positions of 
phenanthroline labeled as i and o in the spectrum. Protons labeled as m and k were the next 
most deshielded protons corresponding 4 and 7 positions of the phenanthroline group 
appeared at 8.28 ppm and 7.77 ppm respectively. Two protons in 3 and 8 positions of 
phenanthroline labeled as n and j appeared at 7.69 ppm and 7.68 ppm respectively. A 
singlet appeared at 7.62 ppm labeled as I corresponds to the proton closer to -NH group in 
80 
the bridge between the BODIPY core and the phenanthroline group. The amme 
substituent's aromatic protons in the BODIPY core, labeled a, b, c, and d resulted in down­
field at 7.53 ppm, 7.49 ppm, 7.38 ppm, and 7 . 12  ppm respectively. The methyl groups 
bound to the BODIPY core adjacent to the nitrogen atoms, labeled as h, experienced a 
downfield shift to 2.30 ppm. The quartet at 2.01 ppm labeled as f corresponds to the -CH2 
in the ethyl group bound to BODIPY core. At 1 .05 ppm, a singlet appeared which labeled 
as e corresponds to the other methyl group in the BODIPY core. The most shielded -CH3 
protons in the ethyl group labeled as g bound to BODIPY core appeared at 0.76 ppm. 
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3.1.2 X-Ray Crystallography 
Using slow evaporation technique, single crystals of the BODIPY ligands (RH4, RH5, 
RH6, RHIO, RH13) were obtained. Dichloromethane-methanol solvent system was used 
to crystalize the ligands at room temperature. The crystals were mounted on glass fibers 
before data collection. Diffraction measurements were made on a CCD-based commercial 
X-ray diffractometer using Cu-Ka radiation () .. = 0 . 154 18  A 0). The obtained single crystal 
structures of RH4, RH5, RH6, RHIO and RH 1 3  are illustrated Figure 3.1 and Figure 3.2 
below. The structural parameters of five BODIPY ligands are listed in Table 3.1 and Table 
3.4, and selected bond lengths and bond angles are shown in Table 3.2, Table 3.3, Table 
3.5, and Table 3.6. 
Comparing the crystal structures of RH4, RH5 and RH6, it is noteworthy that RH4 has a 
triclinic crystal system with P-1 space group while RH5 and RH6 both possess monoclinic 
crystal system with P21 and P2i/c space groups respectively. The R values were below 5% 
for both RH4 and RH6 crystals indicating the good quality ofrefinement for both RH4 and 
RH6 crystals, but R value was just above 5% for RH5 (5.3%) which was still in the 
acceptable level. Two different conformation isomers were observed for RH4 and four 
different conformation isomers were observed for RH5 while only one conformation 
structure was observed for RH6. The ratio of number of reflections/ number of parameters 
for RH4, RH5 and RH6 were 14.25, 14.5 and 1 5.28 respectively. These values further 
confirmed the quality of data were in a good level. In RH4 crystal structure one 
conformational isomer showed disorder around the bromine atom. Solvent molecule 
(CH2Ch) was also present in RH4 crystal structure. 
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(a) (b) 
F2 
(c) 
Figure 3.1. OR TEP diagrams of the single-crystal structures of (a) RH4, (b) RH5 and 
(c) RH6 with 50% thennal ellipsoid probability. Hydrogen atoms were omitted for 
clarity. 
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Table 3.1. Crystal data and structural parameters for RH4, RH5 and RH6 
RH4 RHS RH6 
Crystal data 
Chemical formula C2sH30BBrF2N20 C26HnBBrF2N20 C21Ih.1BBrF2N20 
Mr 503.22 5 1 7.26 5 3 1 .28 
Crystal system, Triclinic, P-1 Monoclinic, P21 Monoclinic, P2tfc 
space group 
Temperature (K) 100 173 1 73 
a, h, c (A) 1 3 . 1 235 (4), 1 5.0693 (4), 13.9134 (4), 1 0.7963 (6), 22.1 893 ( 13), 
1 5 .4029 (4) 16.9277 (4), 1 1 .4 1 50 (6) 
20.8463 (6) 
ex, p, Y (o) 1 08.293 (2), 1 1 1 .7 1 2  (2), 90, 9 1 . 1 08 (2), 90 90, 99.561 (3), 90 
I 0 1 . 152 (2) 
V (A3) 2 5 1 6 . 1 3  ( 1 3) 4908.8 (2) 2696.6 (3) 
z 2 8 4 
µ (mm-1) 3.50 2.58 2.36 
Crystal size (mm) 0.38 x 0.22 x 0.05 Not Reported 0.35 x 0.22 x 0.08 
Data collection 
T mnh T max 0.564, 0.753 Not Reported 0.565, 0.753 
No. of measured. 56696, 9049, 7829 7295 1 ,  17614, 32276, 4784, 3927 
independent and 1 5028 
observed [J > 
2cr(J)] reflections 
Rini 0.051 0.065 0.093 
(sin Ot?..)max cA-1) 0.603 0.604 0.602 
Refinement 
R[F2 > 2cr(P2)), 0.048, 0 . 1 3 1 ,  1.05 0.053, 0.146, 1 .05 0.045, 0.1 78, 1 .06 
wR(F2), S 
No. of reflections 9049 17614 4784 
No. of parameters 635 1 2 1 4  3 1 3  
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Table 3.2. Selected Bond lengths for RH4, RH5 and RH6 
Bond Lengths (A) 
Bond RH4 RHS RH6 
B-Fl 1 .395(5) 1 .397(6) 1 .401(4) 
B-F2 l .389(3) 1 .406(7) 1 .400(4) 
B-Nl 1 .549(4) 1 .55 1(6) 1 .554(4) 
B-N2 1 .544(4) 1 .546(7) l .553(5) 
Table 3.3. Selected Bond angles for RH4, RH5 and RI 16 
Bond Angles (0) 
Bond RH4 RHS RH6 
N l -B-N2 1 06.7(2) 1 06.8(4) 107.2(2) 
F l -B-F2 1 09.7(2) 109. 1(4) 1 09.1(3) 
N l -B-FI 1 1 0.0(2) 1 1 1 .4(4) 1 1 0.2(3) 
N2-B-F2 1 1 0.7(2) I 09.8(4) 1 1 0.4(3) 
N2-B-FI 109.7(2) 1 1 0.6(4) l 09.8(3) 
N l -B-F2 1 1 0.0(2) 109. 1(4) 1 1 0.0(3) 
-
Most of the crystal parameters of RH4, RH5 and RH6 including bond lengths and bond 
angles were similar to each other as listed in Table 3.2. and Table 3.3. This confirmed that 
changing the length of alkyl group bound to phenolic substituent does not affect the 
conjugated ring system in the BODIPY core and it docs not deviate from the tetrahedral 
geometry around the boron atom. However, the two planes between the aromatic 
substituent and the BODIPY core arc not exactly perpendicular to each other for all three 
ligands. RH5 showed the highest tilting by 1 2.27° while RH4 and RH6 showed 6.68° and 
4.88° respectively. This was the major considerable difference among the crystal structures 
of RH4, RH5 and RH6 ligands. 
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(a) (b) 
Figure 3.2. ORTEP diagrams of the single-crystal structures of (a) RH I O  and (b) RH13 
with 50% thermal ellipsoid probability. 
Considering the crystal data obtained for RH I 0 and RH I 3, both showed monoclinic crystal 
system belonging to the C2/c and P21 space groups respectively. The R values were below 
5% for both RHlO and RH 1 3  crystals indicating the good quality of refinement. No 
conformational isomers were observed any of the crystals. The ratio of number of 
reflections/ number of parameters for RH I 0 and RH 1 3  were I 3 . 1 3  and 13.58 respectively. 
These values further confirmed the quality of refinement is good for both crystals. Due to 
the -NH2 group present in the aromatic substituent in the BODIPY core, two planes were 
tilted by 2 1 .74°in RH10 and 9. 1 1 ° in RH 13  which resulted as the major difference among 
these two crystal structures. This large tilt of the aromatic substituent could be due to the 
hydrogen bonding interaction present between the hydrogens of para amino group and the 
F atoms in an adjacent BODIPY core. Hydrogen bonds are present in the ortho amino 
substituted aromatic ring containing RH I 3 as well yet the orientation has not been changed 
significantly due to the hydrogen bonding directionality is favorable with the more two 
plane perpendicular structure of the RH 13  I igand. 
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Table 3.4. Crystal data and structural parameters for R H I O  and R H 1 3  
RHlO RH13 
Crystal data 
Chemical formula CnH2&BF2N3 C23H2i;BF�N3 
Mr 395.29 395.29 
Crystal system, space group Monoclinic, Cllc Monoclinic, P21 
Temperature (K) 100 273 
a, b, c (A) 1 7.3936 (7), 1 2.2974 7.5651 (6), 17.4444 ( 1 3), 
(5), 1 1 .8024 (5) 8.0325 (6) 
a. p, Y (o) 1 26.5 1 9  (2) 94.221 (5) 
V (A3) 2028.83 ( 15) 1057.16 ( 1 4) 
z 4 2 
µ (mm ') 0.59 0.69 
Crystal size (mm) Not Reported 0.34 x 0.31 x 0.20 
Data collection 
T mm, T mu Not Reported Not Reported 
No. of measured, independent 2 1 247, 1865, 1772 14432,3722, 3256 
and 
observed [/ > 2o(J)] reflections 
R;n1 0.030 0.053 
(sin 0/A.)mnx (A 1) 0.608 0.602 
Refinement 
R[F2 > 2o(F2)], wR(F2), S 0.034, 0.093, 1 .04 0.043, 0. 1 3 1 ,  1 .09 
No. of reflections 1865 3722 
No. of parameters 142 274 
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Table 3.5. Selected bond lengths RH 1 0  and RH 1 3  
Bond Lengths (A) 
Bond RHlO RH13 
B-Fl 1 .409 1 .400(3) 
B-F2 1 .409 1 .408(4) 
B-Nl 1 .548 1 .542(4) 
B-N2 1 .548 1 .548(4) 
Table 3.6. Selected bond angles for RH I 0 and RH 1 3  
Bond Angles (0) 
Bond RH l O  RH13 
N l -B-N2 107.5 107.1(2) 
F l -B-F2 108.2 108.7(2) 
N 1 -B-F l 1 1 0.5 1 1 0.6(2) 
N2-B-F2 1 1  O. l I 09.7(2) 
N2-B-Fl 1 1  O. l 1 1 0.7(2) 
Nl -B-F2 1 1 0.5 I I O. l (2) 
Bond lengths and bond angles of RH I 0 and RH 13 arc very similar to each other. Both 
ligands showed bond angles closer to I 09° indicating the tetrahedral geometry around 
boron atom in the BODIPY core. However, N 1 -B-N2 bond angle ( 1 06°) is quite smaller 
than l 09° identical bond angle in all five crystal structures. 
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3.2. Photophysical Properties 
3.2.1. Photophysical properties of ligands 
3.2. 1 . 1. Absotplion data 
Absorption spectra for both RH l 2 and RH 14  are shown in Figure 3.3 and detailed spectral 
data are listed in Table 3.7. 
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Figure 3.3. Absorption spectra for RH l 2  and R H 1 4  ligands in CH2Ch ( l .6 x t 0·6 M) 
Absorption maxima for RH 14 is 532 nm which is quite higher than for RH I 2 observed 
around 527 nm. 
3.2. 1.2. Fluorescence data 
Excitation and emission spectra for both RH 1 2  and RH 14  are shown in Figure 3.4 and 
Figure 3.5. The detailed spectral data arc listed in Table 3.7. The maximum excitation of 
RH 1 2  was observed around 526 nm but it was observed at 531  nm for R H 1 4. Emission 
maxima for RH 1 2  and R H 1 4  were observed at 540 nm and 548 nm respectively. Higher 
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stokes' shift was observed for R H 1 4 than RH12. With the same concentration, both RH12  
and RH 14 showed more or less equal fluorescence intensities. 
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Figure 3.4. Excitation Spectra of RHl 2 and RH14 ligands in CH2Ch ( 1 .6 x 10-6 M) 
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Figure 3.5. Emission Spectra of RH12 and RH14 ligands in CH2Ch ( 1 .6 x 10-6 M) 
3.2. 1.3. Quantum yield measurements 
As listed in the Table 3.7 quantum yields were calculated by plotting an integrated 
fluorescence intensity vs ahsorhance graph. Two trials were done for the reference 
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rhodamine 6G, RH 1 2  and RH 1 4  samples and average quantum yields were calculated for 
each sample. Figure 3.6, Figure 3.7, and Figure 3.8 illustrate the UV-absorption spectra, 
fluorescence spectra, and integrated fluorescence intensity vs absorbance graph of different 
concentrations of  RH 12  for the trial I measurements. Figure 3.9, Figure 3.10, and Figure 
3.1 1  illustrate the UV-absorption spectra, fluorescence spectra, and integrated fluorescence 
intensity vs absorbance graph of different concentrations of RH 14 for trial l measurements. 
0.6 
0.5 
Q) 0.4 u c 0.3 "' ..0 i... 0 0.2 en ..0 
<!'. 0 l 
0 
400 
·0.1 
Absorbance vs Wavelengths/ nm 
420 440 460 480 500 520 
Wavelengths/ nm 
-- I O uL 
40 uL 
--60uL 
-- 90 uL 
540 560 580 
Figure 3.6. Trial 1 - UY-absorption spectra of RH12 with four different concentrations in 
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Figure 3.8. Trial 1- Integrated fluorescence vs absorbance graph for quantum yield 
determination of RH 1 2  
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Figure 3.10. Trial I- Emission spectra of RH 14 with four different concentrations in 
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Figure 3.1 1. Trial /- Integrated fluorescence vs absorbance graph for quantum yield 
determination of RH 14 
Figure 3.12, Figure 3.13, and Figure 3.14 il lustrate the UV-absorption spectra, 
:fluorescence spectra, and integrated fluorescence intensity vs absorbance graph of different 
concentrations ofRH12  for the trial 2. Figure 3.15, Figure 3.16, and Figure 3.17 illustrate 
the UV-absorption spectra, fluorescence spectra, and integrated fluorescence intensity vs 
absorbance graph of different concentrations of RHl 4 for trial 2 measurements. 
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Figure 3. 12. Trial 2- UV-absorption spectra of RH 12  with five different concentrations 
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Figure 3.13. Trial 2- Emission spectra of RH 1 2  with five different concentrations in 
A RH 1 2  stock solution with 2 . 1 6  x I 0-4 M concentration was used to record above 
absorption and emission spectra. Integrated fluorescence vs absorbance emission graph 
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was plotted using above absorption and emission spectra as il lustrated in Figure 3.14. 
The gradient was used to calculate the quantum yield of RH 1 2. 
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0.6 
0.5 
0 4  v (.) c:: 0.3 «:! ..0 ..... 0 0.2 Cl) ..0 
<t'. 0 1  
0 
400 
·0.1 
Absorbance vs Wavelength/ nm 
--2o uL 
--45 uL 
70 uL 
95 uL 
-- 120 uL 
420 440 460 480 500 520 540 560 580 
Wavelength/ nm 
Figure 3.15. Trial 2- UV-absorption spectra of RH 14 with five different concentrations 
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Figure 3.17. Trial 2- lntegrated fluorescence vs absorbancc graph for quantum yield 
determination of RH14 
A stock solution of RH 14  with 1 .93 x 10-4 M concentration was used to record above 
ahsorption and emission spectra. Integrated fluorescence vs absorbance emissions graph 
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was plotted using above absorption and emission spectra as il lustrated in Figure 3.17. 
From integrated fluorescence vs absorbance plots obtained for two trials, two quantum 
yield values were calculated and average values are reported in Table 3.7. Refractive index 
of CH2Cli was used as 1 .4244 and for ethanol 1 .36 1 7  at 20°C. lt turned out that the quantum 
yield of RH 14 was 20% higher than RH 12. 
3.2.1.4. Lifetime measurements 
The lifetime (vis) of RH14 was higher than the lifetime of RH l 2  as listed in Table 3.7. 
This higher lifetime could be an advantage in indirect energy transfer process of RH 1 4  
compared to RH 12. 
Figure 3.18. Single Exponential Tail titting of lifetime for RH 12 in CH2C'2 at room 
temperature at 537 nm 
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Figure 3.19. Single Exponential Tail fitting of lifetime for RH 14 in CH2Ch at room 
temperature at 549 nm 
T bl 3 7 Ph a e . . h . 1 otop 1ys1ca properties o 
Ligand AAbs (nm) Aex (nm) �m (nm) 
RH 1 2  527 526 540 
RH14  532 531 548 
f RH 1 2  d RH 1 4  I' d an 1gan s 
Astokcs Lifetime/ Quantum 
(nm) (vis) ns Yield 
14 4.97 0.55 (±0.0 I )  
1 7  7.56 0.78 (±0.06) 
3.2.2. Photophysical properties of lanthanide complexes 
Complex formation was studied and confirmed by NIR emission signals corresponding to 
the Yb(III) ion around 980 and I 0 1 0  nm range. With both RH 1 2  and RH 14 ligands, strong 
emissions were observed in the NIR region confirming complex formation. In this study 
(Yb(TPP)(OAc)(McOHh] complex was used to synthesize the lanthanide complex. 
Porphyrin alone can sensitize Yb(III) ion to emit around NIR region. To understand the 
contribution from each conjugated system to sensitize Yb(IIr) NlR emission, an excitation 
spectrum was recorded monitoring the emissions at 980 nm. 
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3.2.2.1. Interaction of RH/ 2 with [Yb(TPP)(OAc)(MeOH)2} in CH2Ch (formation of 
complex I) 
First, excitation spectrum was recorded for the complex I to investigate the excitation 
maxima of the complex I Figure 3.20. (a). The highest excitation was observed at 440 nm 
and the second highest excitation was observed at 527 nm. These are compatible with the 
excitation maxima of porphyrin and BODIPY unit respectively. At 440 nm, the porphyrin 
unit can be excited to sensitize the lanthanide ion and at 525 nm BODIPY unit can be 
excited to sensitize the lanthanide ion to emit in the NIR region. Then emission in the NIR 
region was recorded at 440 nm and 525 nm along with two other wavelengths at 375 nm 
and 550 nm as i llustrated in Figure 3.20. (b ) . 
For both 440 nm and 525 nm emission intensities, the NIR region was more or less similar 
and it was higher than when the other two wa¥elengths were used, concluding the 
sensitization process is achieved by both porphyrin and BODIPY units in the complex l .  
Maximum NIR emission peaks were observed at 977 nm and l 005 nm. These can be 
assigned to typical Yb(III) transition between 2Fs12 ground state and 2F1112 excited state of 
the BODIPY based Yb(III) porphyrin complex. 
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Figure 3.20. (a) Excitation Spectrum (A.cm= 980 nm) (b)NIR emission under different 
excitation wavelengths for complex l 
3.2.2.2. Interaction of RH/ 4 with {Yb(TPP)(OAc)(MeOHh} in CH2Cl2 (formation of 
complex 2) 
Similar results were observed for complex 2 ([Yb(TPP)(OAc) RH14]) as illustrated in 
Figure 3.21. but the highest emission was observed at 440 nm and the second highest 
emission was observed at 527 nm. In contrast to complex I ,  complex 2 NIR emissions were 
higher at 550 nm as depicted in Figure 3.22. Maximum NlR emission peaks were observed 
at 978 nm and I 006 nm. These can be assigned to typical Yb(HI) transition between 2Fs12 
ground state and 2F1112 excited state of BODTPY based Yb( Il l)  porphyrin complex. 
101 
toO 1000 ,. W-.gtllnm 1100 
(a) Contour view 
1150 
< IOO 
MO E � .c IOO f • 
"° i 
! 
olOO ii: 
MO 
(b) 30 view 
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3.2.2.3. Spectroscopic ti/rations with RH/2 and RJl/4 /igands 
The RH 1 2  ligand shows strong fluorescence in the visible region but when it forms the 
complex with Yb(III) fluorescence was almost completely diminished as shown in Figure 
3.23 (a). Upon addition of Yb(III) ions to the RH 12 solution, the fluorescence intensity at 
540 nm gradually decreased until the molar ratio of RH 1 2  to Yb(IU) becomes I :  I .  Further 
addition of Yb(HI) ions did not exhibit considerable level of fluorescence decrement. f n 
contrast, emission intensity at 977 nm increased by increasing the Yb(IID during the 
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titration process. This observation further confirmed the indirect lanthanide sensitization 
process by BODIPY based ligands. 
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Figure 3.23. Interaction of RH 12  with [Yb(TPP)(OAc)(MeOHh] in CH2Ch (a) visible 
emission from RH 12 (b) NIR emission from Yb(Ill). 
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Figure 3.24. Back titration by RH 12, NTR emission from Yb(III) at 977 nm and l 005 nm 
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To confirm the stoichiometric ratio between Yb(TII) and RH 12 ligand, back titration was 
done (Figure 3.24.). (Yb(TPP)(OAc)(McOH)2] was titrated by RH 1 2  ligand and NTR 
emission by Yb(III) was monitored with added ligand volumes. When increasing the ligand 
concentration, NIR emission by Yb(ITI) increased and increment was continued until the 
molar ratio becomes I :  l .  This observation further confirms the [Yb(TPP)(0Ac)t3 forms 
1 :  1 complex with RH 12. 
RH14+Yb-MeOH 
:;j 
.i 
?:--;;; c Q) £ 
500 550 600 650 
Wavelength (nm) 
:;j 
� � u; c $ 
E 
RH14+Yb 
900 950 
1006 
1000 1050 1100 1150 
Wavelength (nm) 
Figure 3.25. Interaction of RH 14 with in CH2C'2 (a) visible emission from RH 1 4  (b) NIR 
emission from Yb(Jll). 
Like RH 12, the RH 14 ligand shows strong fluorescence in the visible region but when it 
forms the complex with Yb(Ill) the fluorescence was diminished as shown in Figure 3.25 
(a). Upon addition of Yb(lll) ions to the RH 14  solution, the fluorescence intensity at 548 
nm gradually decreased until the molar ratio of RH 14 to Yb(lll) becomes I :  I .  
Considerable change in the emission spectra could not be observed by further addition of 
Yb(lll) ions. Considering the emission intensity at 977 nm, it increased with increasing 
Yb(III) concentration during the titration process. This observation also supports the idea 
of indirect lanthanide sensitization mechanism by BODlPY based ligands. 
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Figure 3.26. Back titration by RH 14, NTR emission from Yb(III) at 977 nm and I 005 nm 
For further confirmation of the stoichiometric ratio between Yb(III) and RH 14 ligand, back 
titration was done. [Yb(TPP)(OAc)(MeOH)2] was titrated by RH 1 4  ligand and NIR 
emission by Yb(III) was monitored with varying ligand concentrations. When increasing 
the ligand concentration, NIR emission by Yb( III) increased and increment was continued 
until the molar ratio becomes 1 :  1 .  This observation further confirms the [Yb(TPP)(OAc)] tJ 
forms I :  I complex with RH14.  
3.2.2.4. lifetime at NIR region 
NIR decay curves were acquired using an optical parametric oscillator. For the complex I ,  
the NTR lifetime was 12.2394 µs. For the complex 2 ,  the NIR l ifetime was 8.8636 µs. Even 
though the quantum yield, visible lifetime and NlR emission intensity were higher for 
RH 1 4  by itself, when it forms the lanthanide complex, a lower NIR lifetime was found than 
the corresponding complex formed with RH 12.  
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Figure 3.28. NIR decay curve for complex 2 recorded at 980 nm 
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CHAPTER 4 
CONCLUSION 
As a remedy for prevailing analytical techniques with fluorophores, BODTPY based 
lanthanide complexes have been synthesized for the past decade. BODIPY molecules are 
low molecular weight fluorophores that show narrow emission bandwidths with high 
extinction coefficients. Furthermore, alterations of the absorbance and emission spectra is 
possible by introducing substituents to the BODIPY core. They are photostable and possess 
relatively longer excited-state lifetimes compared to many other fluorophores. 
Functionalizing the BODIPY core with ligand binding groups allow it to form stable 
lanthanide complexes. These BODIPY based lanthanide complexes show unique emission 
bands at NIR region. Synthesizing such complexes and utilize the selective and sensitive 
emission properties of lanthanide ions and harvesting the benefits to analyze biological 
systems is one promising area in recent medical diagnostic studies. 
As a contribution to such diagnostic studies, in this study, two new BODIPY functionalized 
ligands were synthesized and their structural and photophysical properties were evaluated. 
A ligand with a phenanthroline group attached to ortho position of the aromatic meso 
substituent (RH14) demonstrated higher quantum yield and visible range lifetime than the 
ligand with phenanthroline group attached to para position of the aromatic substituent 
(RH 12). Both ligands emit strong fluorescence; however, fluorescence was quenched upon 
the addition of [Yb(TPP)(OAc)(MeOH)2]. In the meantime, NIR emission by Yb(III) 
around 977-1 006 nm range was gradually increased exhibiting a lanthanide metal and 
ligand interaction. Lanthanide ions formed 1 :  1 metal to ligand complex showing a dextre 
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type sensitization mechanism. However, excitation at different wavelengths suggested both 
porphyrin and BODIPY moieties responsible for the sensitization process of these 
complexes. 
Results showed the capability ofBODIPY functionalized with phenanthroline can function 
as an efficient chromophore for the indirect sensitization of lanthanide complexes. 
However, NIR emission was hindered when using [Yb(hfa)3 (H20)2] as the ytterbium 
source for both synthesized ligands. Therefore, further studies should be carried out to 
understand the underlining chemistry behind the NIR emission efficiency of both 
complexes formed by [Yb(TPP)(OAc)(MeOH)2] and BODIPY ligands (complex l and 
complex 2). 
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